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Abstract
Two primer sets were manufactured from the cytadhesin PI gene of M. Pneumoniae
in an attempt to amplify homologous sequences inM mycoides subsp. mycoides “SC” Type
in a search for a PI-like gene in the latter organism. The first primer set MP-2 amplifies a
488 bp fragment in M. pneumoniae. The second primer set MP-3 amplifies a 303 bp
fragment bracketing the 13-amino acid binding domain in the same organism.
Both primer sets amplified the expected fragments in all the virulent strains of M.
mycoides subsp. mycoides “SC” type. The primer sets did not however amplify the
expected fragments in the vaccine T1 strain of the organism.
A third primer set (MP-V) was then selected from the sequence of the CAP-21 gene
insert described by Taylor et al, 1992. This primer set amplifies a 458 bp fragment in all
members of the M. mycoides cluster including the T1 strain. The primer set amplified the
expected fragment in all the virulent strains as well as the T1 vaccine strain of M. mycoides
subsp. mycoides “SC” type but did not amplify it in M. pneumoniae and M. genitalium.
A comparison of the protein pattern of the virulent strain PG1 and the vaccine T1
strain of M. mycoides subsp. mycoides “SC” type revealed considerable protein differences.
A multiplex PCR assay was then developed to differentiate the virulent strains from
the T1 vaccine strain of M. mycoides subsp. mycoides “SC” type using the primer sets MP3 and MP-V. The assay amplified two fragments in all the virulent strains of the organism
(the 303 bp and the 458 bp) and only one fragment (the 458 bp) in the T1 strain thereby
differentiating the strains in one amplification procedure.

xi
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The assay was then employed to test crudely prepared field samples from cattle
suspected o f CBPP infection but previously vaccinated with the T1 strain.

xii
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Chapter 1. Contagious Bovine Pleuropneumonia: The Disease and the Etiological
Agent in Somalia

Introduction:
The disease contagious bovine pleuropneumonia (CBPP) is an infectious disease
caused by Mycoplasma mycoides subspecies mycoides “small colony (SC)” type and is
endemic in many parts of the world. It particularly poses serious socioeconomic problems
in subsahara Africa. In Somalia, where the economy is dependent on the export of live
animals, CBPP has had great impact on the overall economy of the country because of trade
bans. These trade bans came as a result of serologically detecting antibodies against the
etiologic agent or microbiologically isolating it. Since Somali cattle are vaccinated before
shipment, it has been and continues to be a problem differentiating vaccinal antibodies from
natural infection antibodies. It has also been impossible with the available diagnostic
procedures in Somalia to differentiate the virulent strains of the etiologic agent from the
vaccine T1 strain which is used in Somalia to vaccinate cattle against CBPP. A solution to
either one of these problems could significantly stabilize the economy by laying a solid
foundation against bans when antibodies detected in the export cattle can be ascribed to the
vaccine strain T1 or an isolated agent can be proven not to be the virulent strain.
The vaccine strain was derived from the virulent strain by serial passaging, therefore
it appeared reasonable to use molecular biology techniques to differentiate the two strains
at the genetic level. In addition, these differences at the molecular level could potentially
answer some of the unknown aspects of the disease and the etiologic agent.

I
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Therefore, the major objective of this research was to identify a molecular
difference between the virulent and vaccine strains and to exploit this difference to develop
an epidemiologic tool for strain differentiation in field specimens. This research was also
initiated to provide a tool which may be useful to identify CBPP infections in field samples.
Use of this tool could also provide a rational approach for reducing outbreaks due to the
virulent strains by detecting animals that are carriers and those that are incubating the
disease. With these goals in mind, the search for a difference between the virulent strain
and the vaccine strain was began. Since the state of avirulence of the vaccinal T1 strain
suggested that mutations may have occurred in one or more of the virulence genes during
passaging, we exploited the close relationships between mycoplasmas and used sequences
from the virulence gene PI of Mycoplasma pneumoniae to detect homologous sequences
in M. mycoides subsp. mycoides “SC” Type. M. pneumoniae is pathogenic and has tropism
for the human lung tissue. Besides, its PI virulence gene has homology sequences with the
PI-like virulence genes of M. genitalium, and M. gallisepticum. Therefore, we
hypothesized that since M. mycoides subsp. mycoides also is pathogenic and has tropism
for the lung tissue of cattle, a gene similar to the PI gene may also exist in it.
The investigation into the possible presence of a cytadherence gene in M. mycoides
subsp. mycoides “SC” Type is discussed in chapter two. Chapter three describes the
development of a multiplex PCR assay for the differentiation of the virulent strains from
the vaccine T1 strain in purified DNA and in field samples from Africa. The fourth and
final chapter gives some guidelines on conducting investigations that require repeated
sampling in the nomadic population of Somalia.
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(1). To identify the presence of the “putative” cytadhesin gene of M. mycoides subsp.
mycoides “SC”type and determine if differences in genetic sequences of this gene exist
between the virulent and vaccine strains.
(2). To develop a multiplex PCR assay that can distinguish the virulent strains of M.
mycoides subsp. mycoides “SC” type from the vaccine strain Tl.
(3). To characterize the PCR assay to differentiate between virulent and vaccine strains of
M mycoides subsp. mycoides “SC” type in field specimens.
(4). To develop guidelines for sampling of nomadic populations of Somalia for potential
use of the ppolymerase chain reaction assay for detection of CBPP infection in Somali
cattle in particular and African cattle in general.
(5). To characterize the sensitivity and specificity of the multiplex PCR assay both in
detecting virulent strains and also in differentiating the virulent strains from the vaccine Tl
strain. Also characterize the specificity by using other mycoplasmas that also affect cattle
and other wild bovids.
(6). Ascertaining the correct use of the multiplex assay in categorizing the virulent strains
and the Tl vaccine strain so that a correct appraisal can be made about mycoplasma
isolations in the export cattle of Somalia. This will help concince importing countries about
isolates of mycoplasmas made in their laboratories.
(7). Establish both the epidemiological and microbiological sensitivity of the multiplex
polymerase chain reaction assay.
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Background and literature review:
Contagious bovine pleuropneumonia is a highly transmissible, highly contagious
and economically important disease of Bos taurus (European cattle) and Bos indicus (zebu
cattle) and some wild bovids (Priestley, 1960; Kamara, 1975; Abdalla, 1975; Provost, 1987;
Paling et al, 1988). It is not known if the disease affects camelids although antibodies
against Mycoplasma mycoides subsp. mycoides were serologically detected in llamas in
South America where the disease has not been reported and in camels (Camelus
dromedarius) in Africa (Hung et al, 1991; Paling et al, 1988). Generally European cattle
are more susceptible than zebu cattle and animals over the age of two years are at an
increased risk of contracting the disease.
The disease is endemic in the continents of Africa, Asia, Southern Europe and
possibly Eastern Europe and the former Soviet Union (OIE-FAO, 1991; FADR, 1991;
Prosperi et al, 1991). Mass vaccinations in Somalia and other African countries may have
reduced the incidence of the disease but economic losses from the disease are still high
(Provost, 1987; Kalif, 1992). One of the economic side effects of CBPP is that trade of
livestock and its products from Africa to the rest of the world is virtually non-existent
largely because of the fear of importing depopulating diseases such as CBPP, rinderpest,
FMD, etc. The reduction in CBPP incidence as a result of mass vaccinations brought about
an increase in the animal population which is not offset by offtake in export. This resulted
in overgrazing and contributed to the desertification of Somalia.
In countries like Somalia whose economy is totally dependent on the export of live
animals (over 80% of Somalia’s foreign earnings come from the export of livestock), trade
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bans instituted to prevent importation of CBPP can have severe socioeconomic
consequences. The 1983 Saudi Arabian ban of Somali cattle imports caused the total
collapse of the Somali economy and was a large contributing factor to the civil unrest that
begin in the north and culminated in the present anarchy. Previously Saudi Arabia had
absorbed 70% of Somali livestock exports (MLFR, 1988-89; Kalif, 1992). The ban was
imposed after Saudi Arabia claimed to have detected animals positive for the presence of
CBPP and rinderpest antibodies. Both diseases are however endemic in Saudi Arabia (OIEFAO, 1991). Somali cattle, especially those for export are vaccinated against both diseases
before shipment (Kalif, 1992).
While outbreaks of CBPP are reported in Somalia in all seasons, generally, as in
other countries, it is more frequent in the two dry seasons (January-April; August-October)
possibly because of the high animal density at watering points along the two rivers and at
the boreholes in the countryside and also because of the effect of poor grazing opportunities
on the animals (Kalif. 1992; Nwanta et al, 1992). Highly morbid, the mortality rate depends
on the season but it is not unusual to see case fatality rates (CFR) as high as 70%. In
Somalia, there are many factors that contribute to the propagation and persistence of CBPP:
a. The cool and humid climate in the rainy seasons.
b. The constant seasonal and trade movement of cattle.
c. The enormous congregation of livestock at watering points during the dry seasons.
d. The scarcity of grazing during the dry seasons, which adversely affects the animal’s
ability to resist pathogenic microorganisms.
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e. The traditional small enclosures where animals are kept during the night from wandering
out, a protection against wildlife and human predators.
f. The lack of vaccines in the inaccessible areas of the interior.
The disease has a subacute, acute and chronic forms. The latter is very important in the
epidemiology of the disease. Under stressing conditions, chronic cases disseminate the
causative agent while the animal shows no clinical signs, serologically tests negative, and
can only be diagnosed at postmortem (Politz, 1976; Provost, 1987). The agent can,
however, be recovered from the ear canal and respiratory tract of apparently healthy
animals that have a history of natural infection (DeMassa, 1990; Masiga et al, 1973). In
addition, the CBPP agent has been recovered from both healthy and diseased goats and
sheep but it is not clear if this has any epidemiological significance especially in countries
like Somalia where families rear cattle, goats, sheep and camels together (Ojo, 1987;
Brandao, 1995; DaMassaetal, 1991; Machado et al, 1985).
CBPP is often clinically complicated and/or precipitated by other diseases such as
hemorrhagic septicemia (HS), bovine viral disease (BVD), trypanosomiasis, etc. and
stressing factors such as vaccinations, long seasonal or trade movements, etc (Onoviran et
al, 1977). In an epidemic outbreak within a given herd, the disease assumes an explosive
character at the beginning and then both morbidity and mortality rates tend to decrease. It
was found and experimentally reproduced that organisms isolated at the end of the outbreak
are less pathogenic than those isolated at the beginning of the outbreak (Bygrave et al,
1968).
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Diagnosis of the disease:
The diagnosis of CBPP is based on clinical and postmortem findings and on
microbiological and serological laboratory procedures. In countries where the disease is
endemic, the clinical and postmortem picture is sufficient for a diagnosis although the
clinical picture is less defined in the mild form of the disease where the classical symptoms
are sometimes not clearly manifested (Kalif, 1992). The microbiological diagnosis of the
disease requires isolation of the etiologic agent which is difficult, tedious, and costly both
in time and money (Gaillard-Perrin et al, 1987). As a consequence, various serological tests
have been developed and extensively used in the diagnosis of the disease (Campbell et al,
1953; Lindley, 1958; Cottew, 1960; Shifrine, 1967; Ladds, 1969; Onoviran et al, 1979;
Provost, 1987; Zhao et al, 1990). The usefulness and interpretation of these tests are
however limited and made more difficult by non-specific and cross-reactions and by their
lack of insensitivity to chronic carriers and animals incubating the disease (Politz, 1976;
Etheridge et al, 1987; Kalif, 1992; Kibe et al, 1985). Besides, serological tests are not able
to differentiate between antibodies produced as a result of vaccination and those produced
by natural infections (Roberts et al, 1974). Such tests would be especially useful for the
surveillance and monitoring of the disease in general and among the export cattle of
Somalia in particular.
In light of the short-comings of the serological tests, DNA probes have been developed
for the diagnosis of mycoplasmal diseases of other animal species (Ahrens et al, 1991;
Hyman et al, 1989; Levisohn et al, 1989; Zhao et al, 1990; Kunita et al, 1989; Narita et al,
1992). Although highly sensitive and highly specific, one of the limitations of these probes
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is their need for the presence of at least 1 ng o f mycoplasma DNA for detection. That
amount of DNA corresponds to DNA of about 106 mycoplasma bacterial cells, which can
only be found in the acute phase of the disease in the live animal when the disease is
clinically evident (Nascimento et al, 1990). In addition it requires highly trained technicians
to conduct it and days to perform it.
Given the problems associated with probes, Polymerase Chain Reaction (PCR) assays
have been developed for Mycoplasma gallisepticum, a poultry pathogen, and Mycoplasma
pneumoniae, a human pathogen (Nascimento et al, 1990; Narita et al, 1992), and for the
agent of CBPP (Dedieu et al, 1994; Bashiruddin et al, 1994). Highly sensitive and highly
specific, the Nascimento assay, for instance, detected 102 pg of M. gallisepticum DNA, a
fraction of the total chromosomal content of a single mycoplasma cell (Nascimento et al,
1990). The only drawback with PCR assays is the need to know, beforehand, part of the
DNA sequence of the fragment to be amplified to synthesize specific primers (Saiki, 1989).
Besides, they need skilled technicians and laboratories with the required equipment. Their
sensitivity, specificity, and cost-effectiveness make PCR assays the best tool in diagnosing
CBPP so that effective control measures can be instituted before an outbreak occurs.
However, no PCR assay has ever been developed to differentiate the virulent strains from
the vaccine strains. For that matter, no test has ever been developed for the differentiation
of these strains.
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Control measures in Somalia:
The country had never developed an effective control program for the disease mainly
because of the problematic practices inherent in the nomadic form of livestock rearing. The
policy for control had always been one of outbreak containment and vaccination of affected
herds. The Tl vaccine broth used in Somalia (and the rest of Africa) is an effective vaccine
that produces an immunity that lasts for about a year. However, distinguishing animals
vaccinated against CBPP from non-vaccinated ones was not possible in Somalia since cattle
owners dislike the idea of having their cattle ear-punched every year after each CBPP
vaccination. With rinderpest, hemorrhagic septicemia and anthrax vaccinations also
requiring ear-punching, the animals are subjected to ear-punching at least three times a
year. This practice tends to mutilate the ears of the animals and thus the reluctance of the
owners to vaccinate their herds. The Somali government also instituted a policy of
vaccinating against CBPP and some other diseases all animals intended for export at least
three months prior to their shipment to the Arabian countries. The policy was adopted
simply to forestall outbreaks of these diseases during the stressful journey. Antibiotic
treatment is prohibited for export animals within 45 days of shipment. The vaccination
practice especially against CBPP created a furor when the importing countries detected
antibodies against CBPP or isolated the etiological agent from the animals. Since it is
impossible to distinguish vaccination antibodies from natural infection antibodies or
virulent strains from the vaccine strain with the conventional tests available in Somalia at
the time, the need arose for a rapid and simple test that can distinguish the virulent strains
of the agent from the vaccine strains.
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The problem of CBPP control in Somalia is also compounded by the transhumant
nature of the nomadic population who own more than 95% of the livestock population.
Their seasonal movement in search of water and grazing involves not only the crossing of
intra-regional boundaries within Somalia but also moving across international borders into
the neighboring countries of Kenya, Ethiopia, and Djibouti and vice versa. The logistical
problems involved in vaccine production and maintaining an effective cold chain and the
difficult task of locating herds in constant movement in the interior of the country are just
a few of the factors that limit mass vaccination in Somalia. The only feasible time of the
year when one can expect to find (and be able to vaccinate) at least a majority of the cattle
is during the two dry seasons when all animals congregate at the watering points if the
animals can stand the stress of the season and the additional stress of being vaccinated.
Controlling or aiming at the eradication of CBPP in one African country without a
coordinated effort to control and eradicate it in neighboring countries is an exercise in
futility given the transhumant nature of nomadic populations in moving across international
borders in search of grazing and watering. This is especially true in the nomadic
populations of East Africa and the Sahel region of West Africa.
Until the start of the civil in 1991, the country used to produce enough Tl vaccine for
all its needs and more to sell to other countries. Sadly both the vaccine institute and its
technical staff have been totally and completely destroyed in the civil war. Rebuilding the
institute is going to be an expensive undertaking but one that is necessary.
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The agent: mycoplasmas in general:
Ecology;
Saprophytic and pathogenic mycoplasmas of animals, humans and plants exist in
nature. Unculturable Mycoplasma-like organisms (MLOs) have also been isolated from
both plants and animals including arthropods (Razin, 1992). Mycoplasmas are generally
host specific. One of the major obstacles in controlling pathogenic mycoplasmas is the fact
that almost all of them have no known natural reservoirs.

Taxonomy:
It is believed that mycoplasmas arose by degenerative evolution from the
Lactobacillus-Streptococcus subgroup of gram-positive, spore forming eubacteria, losing
their cell wall in the process (Maniloff et al, 1981). Taxonomically, mycoplasmas are
grouped in the class Mollicutes (soft skin) of the Tenericutes (wall-less bacteria) division,
which is one of the four divisions of the kingdom Procaryotae. They belong to the order
Mycoplasmatales. Although distinguishable on the basis of morphology, metabolic
properties and genome size, members of the order Mycoplasmatales are further
differentiated on the basis of their requirement of sterol for growth;
Mycoplasmataceae

and

Spiroplasmataceae

require

sterol,

while

The families
the

family

Acheloplasmataceae does not (Edward et al, 1970; Whitcomb et al, 1980; Christiansen,
1987; Pathak et al, 1988). New mycoplasmas however are being identified regularly and
the taxonomy keeps changing. Of all the Mycoplasmas, M. neurolyticum, a mouse
pathogen, is the only one that produces a toxin, a neurotoxin in this case.
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Structure and biochemical properties:
Generally, mycoplasmas catabolize glucose, and hydrolyze arginine and urea. They
grow in the presence of 5% C02. They assume the classical fried-egg shape in solid media,
while in liquid media they form filaments of various sizes (Razin et al, 1992). Their size
ranges from 0.3-0.8 i*m in diameter (Pathak et al, 1988). They are sensitive to heat,
sunlight, ultraviolet rays, and all common disinfectants.
Structurally, they are composed of an outer envelope (capsule), cytoplasmic
membrane, cytoplasm and nucleus. The envelope of M. mycoides subsp. mycoides is a
galactan (polymers of the polysaccharide galactose). The capsule polysaccharide has anti
phagocytic properties, which allows the organisms to grow on the surfaces of macrophages
and neutrophils without activating the phagocytic process (Maniloff, 1992). The galactan
of M. mycoides is not immunogenic unless combined with protein macromolecules or
Freundt's adjuvant (Maniloff, 1992). It has similarities with the pneumogalactan of cattle,
a normal lung epithelial cell product (Maniloff, 1992). The galactan is also produced by
other eubacteria (Diplococcuspneumoniae, Actinobacillus lingneresi, E.coli, Aeromonas,
Corynebacterium), and plants (Maniloff, 1992). The membrane is composed of three layers:
A lipid layer sandwiched between two protein layers. The membrane antigens are soluble.
While Mycoplasmas are sensitive to the elements when outside their hosts, they
however possess enormous survival abilities inside the host against the host’s defence
mechanism.
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Genome:
Mycoplasma and Ureoplasma species have genome sizes that vary from 500 bp to
1,300 bp, while Achelopalsma and Spiroplasma have genome sizes in the range 1,3501,700 bp. Mycoplasma have a circular double stranded DNA (Razin et al, 1992).
The G+C content of mycoplasma DNA falls within the range 24-33 mol%. Some
of the adenine and cytosine residues in mycoplasma may be methylated. Bovine Group 7
and the SC type of M. mycoides subsp. mycoides lack methylation at the GATC site while
the LC type possesses methylation at this site (Razin et al, 1980).
The mycoplasma genome has a high A+T content with M. capricolum possessing
the highest content (75%) (Dybvig, 1990). Generally, spacer regions between genes are
80% A+T; protein genes are about 70% A+T; rRNA and tRNA coding regions with about
50% A+T (Dybvig, 1990). As a result of the high A+T content, denaturation of
mycoplasmal DNA requires higher temperatures than normally required for the
denaturation of other bacterial DNA (Dybvig, 1990).
Mycoplasmas appear to use the codon UGA to code for tryptophan and UAA as
a termination codon (Dybvig, 1990). The other eubacteria use UGG or TGG to code for
tryptophan and UGA as a termination codon (Dybvig, 1990). They may also utilize UGG
(TGG) to code for tryptophan, but because of the bias towards A+T, UGA is the preferred
codon. These observations suggest that mycoplasmas are undergoing a selective pressure
to replace G+C base pairs with A+T base pairs (Dybvig, 1990). This fact has been an
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obstacle in mycoplasma research in molecular cloning and expression techniques in the past
few decades.

Motility:
Some mycoplasmas move by gliding on surfaces. Attachment to surfaces is
required for this gliding motility to occur (Maniloff, 1992). Only pathogenic mycoplasmas
(M mycoides, M. pneumoniae, M. genitalium, M. gallisepticum, M. pulmonis) have this
gliding motility characteristic. These pathogenic mycoplasmas exhibit a filamentous or
flask-shaped polarity of the cell body in light microscopy (Maniloff: 1992).
The cell polarity consists of the presence of terminal organelles or blebs. It is at
these terminal organelles that pathogenic mycoplasmas attach to host cells (Bredt et al,
1977; Hansen et al, 1979,1980; Krause et al, 1982, 1983). The terminal organelles or blebs
are composed of proteins. Some of these have been isolated and their sequence determined
(Su et al, 1987; Inamine et al, 1989; Dallo et al, 1989).
Mycoplasmas also exhibit chemotaxic and rheotaxic behaviour (KirchhofT et al,
1984; Rosengarten et al, 1988). Motility, chemotaxis and rheotaxis are thought to play a
significant role in the pathogenicity of mycoplasmas (Kirchhoff, 1992).

Virulence and pathogenicity:
For pathogenicity, mycoplasma organisms need to adhere to the epithelial cells of
the host. Although the presence of proteins involved in cytadherance have never been
demonstrated in the M. mycoides cluster, different densitometeric patterns were observed
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between the proteins of the virulent M. mycoides subsp. mycoides strain and the vaccinal
strain in acrylamide gel electrophoresis (Stone et al, 1973). The mechanism by which
attenuation occurs through passaging in the T1 strain is not known.

Cytadherance proteins were demonstrated in M. pneumoniae (Baseman et al, 1982;
Krause et al, 1982). Mycoplasma cells that lack these proteins were not able to adhere to
the host epithelial cells and, thus, were not pathogenic. Subsequently, the cytadhesin gene
(PI) responsible for one of the adhesin proteins of M. pneumoniae ( the calculated
molecular weight of the protein is 176,288 kiloDaltons) was identified and sequenced. The
gene, PI, has 4881 nucleotides and is thought to be part of an open-reading frame (Su et
al, 1987).
Using probes made from the cytadhesin gene (PI) of M. pneumoniae, a
homologous sequence was detected in M. genitalium (Dallo et al, 1990). Subsequently, the
cytadhesin gene of M. genitalium was sequenced (Dallo et al, 1989). This cytadhesin gene,
P140, has 5335 nucleotides and codes for a protein of about 160 kDa (The calculated
molecular weight of the protein is 159,668 kiloDaltons). Again, using at low stringency
probes made from the cytadhesin gene PI of A/, pneumoniae, homologous sequences were
detected in both M. genitalium and M. gallisepticum suggesting the possible presence of
a gene similar to the PI gene of M. pneumoniae that code for virulence factors in both
mycoplasmas. All three mycoplasmas are pathogenic and all have tropism for the lung
tissue of their respective hosts (Dallo et al, 1990).
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A group of 13 amino acids were later identified in the PI gene of M. pneumoniae
as the binding domain (Dallo et al, 1991). Although claims of the presence of these 13
amino acids in the PI40 protein of M. genitalium were published by various researchers,
a visual comparison of the published amino acid sequences of PI and PI40, does not
support the claims. The published sequences of the PI gene of M. pneumoniae and PI 40
of M. genitalium do, however, show areas of homology ranging from 62% to 100% (Dallo
etal, 1991).

The etiological agent of CBPP:
The “Small Colony” type of M. mycoides subsp. mycoides is the causative agent
of Contagious Bovine Pleuropneumonia. The “Large Colony” variant causes a complex
disease syndrome including pleuropneumonia, mastitis and arthritis in goats (Ojo, 1987).
Strains are usually given the names of the places from which they are isolated, e.g. the
Gladysdale strain from Australia, Mara, Baringoni, Oremit from Africa. Each type strain
(“LC” or “SC”) is specific for its respective host. i.e. the “LC” type is specific for goats and
the “SC” type is specific for bovids.
Besides host preferences, the “SC” and “LC” types ofM mycoides subsp. mycoides
differ in the quality of their protective antigens. Mice vaccinated with the LC type were not
protected when challenged with the SC type (Smith et al, 1981). The two also differ in their
respective genome sizes. The SC type has relatively a larger genome. The restriction
enzyme Apal does not digest SC type DNA, while it has two restriction sites for the LC
type DNA (Pyle et al, 1990). Protein comparisons between the virulent strains revealed no

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

17
differences and a protein comparison between a virulent strain and the T1 vaccine strain
reported no differences ( Stone et al, 1973). The “SC” and “LC” types also differ in the size
of the respective colonies they form on agar.

Also the vaccine strain T1 used in Somalia and the rest of Africa is a wild strain
attenuated through passaging and is indistinguishable from the virulent field strains in
every respect except in pathogenicity (Brown et al, 1965).

Non-specific and cross-reactions:
While a large antigenic homology exists within the M. mycoides cluster (M
mycoides subsp. mycoides, M. mycoides subsp. capri, M. capricolum, the F38 group, Group
7 of Leach), the CBPP agent has some common antigens with a fairly large number of other
cattle mycoplasmas. These common antigens account for the frequent cross reactions
encountered in serological tests (Vardam et al, 1980; Lefevre et al, 1987; Taylor et al, 1989;
Rose et al, 1989; Gail et al, 1983; Bereiter et al, 1990; Etheridge et al, 1986; Emo, 1987;
Cimolai et al, 1987; Sasaki et al, 1987; Regalia et al, 1988; Leach et al, 1989; Kalif, 1992).
Taylor et al, 1991 found that a probe made from M mycoides subsp. capri detected similar
sequences in the M. mycoides cluster. The probe detected homologous regions in all cluster
strains, but with considerable base differences in the sequence (Taylor et al, 1991)
Etheridge et al, 1976 discovered that other cattle mycoplasmas were responsible
for the cross-reactions to the CBPP agent in Australia where the disease has been eradicated
(Etheridge et al, 1976).
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Sasaki et al, 1987 found significant reactions when pooled human sera was tested
with ELISA and suggested that cross-reactive antibodies to mycoplasma exist in human
sera and that they affect the results of the test (Sasaki et al, 1987).

Besides cross-reactions, non-specific reactions in serological tests employed in the
diagnosis of CBPP make their interpretation more difficult. Various reasons have been
formulated as to the cause of non-specific reactions:
(1). Ansari et al, 1989 attributed it to the storage of serum at +4° C, freezing and thawing
of serum, and inoculation of animals with sterile media (Ansari et al, 1989).
(2). Nicolet et al, 1980 suggested that non-specific reactions are due to components of the
antigen (Nicolet et al, 1980).
(3). Lauerman et al, 1991 demonstrated the presence of IgG-FC receptors in Mycoplasma
sinoviae which reacted with normal serum IgG of different animal species and suggested
that they may be responsible for the non-specific reactions seen in the serums (Lauerman
etal, 1991).
(4). Finally, Kalif (1992) provided evidence of the possible presence of IgG-FC receptor(s)
in M. mycoides subsp. mycoides LC type (Kalif, 1992).

Transmission:
Transmission is principally by aerosol of nasal droplets. Urine aerosol, semen, and
transplacental transmission have all been suggested (Volintir et al, 1971; Masiga et al,
1972; Scudamore, 1976; Emo, 1987; Ball et al, 1987; Provost, 1987). The infective dose

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

19
of the organism is not known but transmissions of 55 meter distance has been reported
(Provost, 1987). The incubation period is not well defined and probably ranges from a few
days to weeks in natural infections depending on the susceptibility of the animal, dose, and
the state of the disease in the area. That is to say whether the area is endemic or it is an area
where the disease appears for the first time. Experimentally the range is from 20 days to
123 days when healthy cattle were placed in contact with infected ones (Provost, 1987).

Unknown aspects of the disease and the etiologic agent:
There are many aspects of the disease and the etiologic agent of CBPP, crucial to the
control and eventual eradication of the disease, that are still obscure and need clarification:
It is known, for instance, that the disease affects some wild bovids (Fisher, 1986;
Provost, 1987). Whether the same strain of the organism causes the disease in both wild and
domestic animals is not known. If the same strain is involved, it is not known whether wild
animals act as natural reservoirs for the agent and contaminate the sources of drinking water
in natural depressions and borehole troughs during the night.
It is also known that the etiologic agent of CBPP has been recovered from nasal swabs
of apparently healthy animals (Ojo, 1987). This fact has fueled suspicion that animals in
the incubation phase of the disease shed the organism silently without showing any clinical
symptoms. This may explain the high morbidity of the disease in outbreaks when many
animals in the herd come down with the disease within a short period of time.
Chronic cases of the disease are virtually impossible to detect with serological tests,
although viable organisms can be cultured from the animal. They are usually detected only
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at postmortem and are important in the epidemiology of the disease because they shed the
organisms in all stressful events (Politz, 1976; Provost, 1987). Why these animqls do not
have an immunological response is not known although it can be speculated that in these
animals, the number of organisms they harbor are not numerically sufficient to provoke a
response. Besides, the viable organisms are usually interned in lung sequestra where they
have no contact with the host’s immune system.
Outbreaks of CBPP have been observed in animals previously vaccinated with live
attenuated vaccines, especially when animals are infected with trypanosomiasis,
dermatophilosis, and other immunosuppressive conditions (Chima et al, 1986; Osiyemi,
1985; Ilemobode, 1982). Whether the vaccinal strain or the virulent “wild” strain is
responsible for these outbreaks is the subject of a continuing debate.
Variations in the severity of the disease from one geographical area to another have
been observed. It has also been noted that isolates from the onset of an outbreak are more
virulent than those isolated at the end of the outbreak (Bygrave et al, 1968). Whether the
strains are being attenuated through the animals they infect or are different strains- some
highly virulent, others with moderate virulence and still others with low virulence involvedis not known.
The CBPP agent has been recovered from ticks and fleas that have, experimentally,
transmitted the disease to susceptible animals (Shiffine et al, 1972; Nayak et al, 1990). It
is not clear whether ticks and fleas act as vectors under normal field conditions or if they
even act as short term reservoirs.
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Finally, presumably because of the manner in which these vaccines are derived, i.e.
extended passaging, it has been virtually impossible to differentiate vaccinal antibodies
from natural infection antibodies (Roberts et al, 1974). Besides, apart from virulence, the
vaccinal strain is impossible to differentiate from the wild virulent strain on cultural and
routine immunological tests. The differentiation between these strains is crucial for
developing countries such as Somalia whose economy is dependent on the export of live
animals.
These aspects of the disease and the causal agent need to be investigated and defined
so that appropriate and meaningful control and eradication programs can be formulated and
implemented with no hidden surprises.
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Chapter 2. Presence of a “Potential” Cytadherence Gene in Mycoplasma mycoides
subsp. mycoides “SC” Type Similar to the PI Gene in Mycoplasma pneumoniae
and the P140 Gene in Mycoplasma genitalium

Introduction:
Mycoplasmas are widely known to cause disease conditions in animals, humans and
plants. In animals, the best known diseases are contagious bovine pleuropneumonia (CBPP)
and contagious caprine pleuropneumonia (CCPP). Both diseases are endemic in Africa and
Asia. CBPP is also endemic in Southern Europe (Provost, 1987; FADR, 1991). Both
diseases are economically important in the affected continents especially in subsaharan
Africa where it causes heavy losses in cattle. The causative agent of CBPP is Mycoplasma
mycoides subsp. mycoides “SC” type.
To be pathogenic, mycoplasma cells need to adhere to the epithelial cells of the host.
The terminal organelles or blebs unique to the flask-shaped mycoplasmas appear to mediate
attachment to host epithelial cells. The mycoplasmal cytadherence proteins are concentrated
at these sites (Kirchhoff et al. 1984; Baseman et al, 1982; Kahane et al, 1985; Krause et al,
1983). Cytadhesin proteins involved in hemadsorption and virulence in M. pneumoniae
have also been described (Krause et al, 1982). The PI protein (170 kDa) of M pneumoniae
has been identified as a major adhesin. When M. pneumoniae cells were treated with
trypsin, it resulted in the reversible loss of the PI protein. Bacterial cells that lost the PI
protein were unable to adhere to epithelial cells and consequently were not pathogenic
(Krause et al, 1983; Gorski et al, 1977; Hu et al, 1976; Hu et al, 1977). The PI protein was
ultimately demonstrated to be localized at the terminal or tip organelle in M. pneumoniae
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(Feldner et al, 1982; Hu et al, 1982; Baseman et al, 1982). It was further demonstrated that
only virulent mycoplasmas cluster the adhesin proteins at the tip organelle (Baseman et al,
1982; Huet al, 1982).
A smaller protein involved in cytadherence was also identified in M. pneumoniae. The
P30 (30 kDa) was similarly clustered at the tip organelle of pathogenic M. pneumoniae. It
was further demonstrated that the P30 and PI proteins of M. pneumoniae have sequence
homologies with each other (Baseman et al, 1987; Dallo et al, 1989; Dallo et al, 1990;
Morrison-Plummer et al, 1986; Su et al, 1987; Inamine et al, 1989).
A protein similar to the PI protein of M. pneumoniae in cytadherence and similarly
localized at the tip organelle was discovered in M. genitalium. The protein, PI40 (160
kDa), has homologous sequences with the PI of M. pneumoniae (Morrison-Plummer et al,
1987; Morrison-Plummer et al, 1987; Hu et al, 1987).
Southern blot hybridization with probes made from the genomic DNA of M.
pneumoniae, M. genitalium and M. gallisepticum and probed against each other showed,
apart from the usual rRNA hybridization bands, other hybridization bands suggestive of
strong genomic homologies (Yogev et al, 1986). Subsequently probes made from the PI
gene of M. Pneumoniae detected homologous sequences in M. genitalium and in M.
gallisepticum at low stringency conditions suggesting the possible presence of a gene
similar to the PI gene in these mycoplasmas. Since all three mycoplasmas are pathogenic
and all have tropism for the lung tissue of their respective hosts, it was further suggested
that a PI-like gene may be conserved in all pathogenic mycoplasmas (Dallo et al, 1990).
Both the PI gene of M. Pneumoniae and the PI40 of M. genitalium were later cloned and
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their sequence determined. Their sequences showed areas of homology ranging from 62%
to 100%. Both genes are over 4kb long (Su et al, 1987; Dallo et al, 1989).
A group of thirteen amino acids were later identified as the binding domain in the PI
gene of M. pneumoniae. There are regions of the PI gene that exist as multiple copies but
the 13-amino acid binding domain exists as a single copy in the gene (Su et al, 1987; Dallo
etal, 1988; Dallo etal, 1991).
Since M. mycoides subsp. mycoides “SC” type is similarly pathogenic and has tropism
for the lung tissue of cattle, as are the other mycoplasmas that possess cytadhesin genes,
it was reasonable to assume that this cattle pathogen may also possess this conserved
cytadhesin gene and that primers and probes made from homologous sequences of the PI
gene of M. pneumoniae and the PI40 of M. genitalium may identify homologous regions
from M. mycoides subsp. mycoides “SC” type.
Therefore this research was conducted to demonstrate the presence of the PI gene
homologue of M. pneumoniae in M. mycoides subsp. mycoides “SC” type.
PCR primers were synthesized based on homologous regions between PI and PI40
sequences and used to amplify DNA from M mycoides subsp. mycoides “SC” type strains.
PCR products were obtained from these reactions and the DNA sequences were determined
using PCR direct cycle sequencing and compared to that of the PI gene. In addition, DNA
probes synthesized by PCR from regions of the “putative” PI gene of M. mycoides subsp.
mycoides “SC” type were used in hybridization experiments to characterize the presence
of this gene in several virulent strains and the T1 vaccine strain of M. mycoides subsp.
mycoides “SC” type. Protein analysis of cell lysates of virulent and vaccine T1 strains were
also performed.
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Materials and methods:
Cultures and DNA extraction:
Purified DNA extracted from five “SC” type strains of M. mycoides subsp. mycoides
were received from Dr. D. Pitcher, British Public Health Laboratory, London, United
Kingdom. The DNA were from four virulent strains (Oremit, PG1, Gladysdale, Poumerat)
and one “vaccinal strain (KH3J)”. The PG1 is the type strain and was isolated in Africa, as
was Oremit: the Gladysdale strain was isolated in Australia; Poumerat is a European strain.
All are highly pathogenic. The KH3J was originally isolated in the Sudan as a virulent strain
and later attenuated and used as a vaccine in some African countries. It was more virulent
than the widely used T1 vaccine strain, which was isolated from an outbreak of CBPP in
Tanzania. The use of KH3J was abandoned in the early 1970's as a vaccine in favor of the
T1 because of the severe reactions it provoked in the animals at the site of inoculation.
More DNA from 4 M. mycoides subsp. mycoides “SC” type strains were extracted at
the Kenya Agricultural Research Institute, Muguga, Kenya by the author. The DNA were
from seven virulent strains (PG1, Oremit, Baringoni, Gladysdale, Iriri, Archer's Post, Mara)
and two vaccinal strains (T1 and KH3J). Six of the seven virulent strains were isolated from
outbreaks of CBPP in Africa.
Strains of M. pneumoniae were received from Dr. David Walker of the University of
Texas Medical Branch at Galveston, Texas. The British, Kenyan and M. pneumoniae DNAs
were kept in separate freezers.
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Culture media:
Culture media for M. mycoides subsp. mvcoides “SC” type strains from London.
England:

The mycoplasma cells were grown on Friis agar in serial dilutions from 10'1to
10‘5 in an atmosphere of 95% N2, 5% C 02 and incubated at 37°C. Single colonies were
picked and subcultured into 2 ml of modified Hayflick’s broth and incubated at 37°C. When
turbid, the 2 ml cultures were subcultured into 400 ml of the same media and incubated at
37°C until late log phase when the indicator begins to change color (Pitcher, 1993). The
modified Hayflick media consists of heart infusion broth (2.85 g); distilled water (90 ml);
these are autoclaved at 121°C for 20 minutes. The following are then added aseptically:
Horse serum (20 ml); calf thymus DNA (1.2 ml of 0.2% solution); fresh yeast extract (20
ml of a 25% solution); thallium acetate (1 ml of a 1% solution); penicillin (0.25 ml of a
20,000 IU/ml solution) and 0.0002% phenol red as the indicator. The pH was adjusted to
7.8 (Pitcher, 1993).

Culture media for M. mvcoides subsp. mvcoides “SC” type virulent and T1 vaccine
strains from Muguga. Kenva:
Newings tryptose broth modified by Gourley, 1964 was used to culture the
bacteria. It consisted of 2% Bacto tryptose (Difco Laboratories, Detroit, Michigan); 0.50%
Dextrose; 0.50% NaCl; 0.25% Na2HP04 (anhydrous); 0.50% Glycerol; 0.10% Yeast
extract, pig serum and the volume brought to 100% with distilled water (Gourley, 1964).
The bacterial cultures were incubated at 37°C until turbid (3-4 days) and then the DNA
extraction procedure described below was followed.
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Culture media for M. pneumoniae:
The SP-4 media was prepared as described by Tully et al, 1979. The media
consisted of 1.5 g of Mycoplasma broth base (Difco Laboratories, Detroit, Michigan), in
67 ml deionized H20, 10 ml of 25% fresh yeast extract (Difco Laboratories, Detroit,
Michigan), 20 ml unheated horse serum (Cell Culture Laboratory, LSU-Veterinary School),
500 units of penicillin G, and thallium acetate (1:2000 final concentration), 0.5% glucose,
0.002% phenol red. The pH was adjusted to 7.8 with 1 N NaOH (Tully et al, 1979).

DNA extraction of M. mvcoides subsp. mvcoides strains from London. UK and
Muguga. Kenva:

The M. mycoides subsp. mycoides DNA was extracted following the procedure
described by Taylor et al, 1992 and modified by Pitcher (1993). The mycoplasma cells were
pelleted by centrifugation at 10,000 X g for 30 minutes at 4°C. The pellet was washed three
times in PBS and resuspended in 5 ml TE. The cells were lysed by the addition of 100 pi
of 25% SDS and 50 pi of 10 mg/m1 proteinase K. and incubated at 37°C for two hours. Rnase A was added to 100 pg/ml and incubation continued at 37°C for another 30 minutes.
The lysate was sequentially extracted with 5 ml volumes of phenol:chloroform:isoamyI
alcohol (25:24:1); chloroform:isoamyl alcohol (24:1). The DNA was precipitated by the
addition of 500 pi of 3 M sodium acetate and 10 ml of ice-cold absolute ethanol. After
centrifugation, the pellet was washed three times in 70% ethanol without centrifugation
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allowing the pellet to stand at room temperature for 5 minutes between washes. The final
DNA was resuspended in TE and stored at -20°C (Pitcher, 1993).

DNA extraction of M. pneumoniae:
The M. pneumoniae culture was centrifuged at 12,000 rpm for 20 minutes in
a JA-17 rotor. The pellet was twice washed in TE buffer and finally resuspended in 1 ml
TE buffer. The DNA was released from the mycoplasma cells by boiling in a 94°C
waterbath for 5 minutes and freezing in -168°C liquid nitrogen for 5 minutes. The boilingfreezing process was repeated two more times. The lysate was centrifuged at 4000 rpm for
eight minutes. The DNA precipitated with I ml 70% ethanol and stored at -70°C for 24
hours. The ethanol was drained off carefully and the DNA resuspended in 200 tA TE. A
small amount of the DNA was diluted 1:30 and spectrophotometric readings taken in UV
at 230, 260, 280 nm to determine amount and purity of DNA. The rest of the DNA was
diluted 1:10 and used in the PCR amplification.

Primers for PCR amplification:
To identify regions for primers to amplify fragments of the “putative” PI gene
of M. mycoides subsp. mycoides “SC” type, the PI gene sequence of M. pneumoniae and
the sequence of PI40 of M. genitalium were compared. Primer sets were selected from
regions of 100% homology between the two strains. Several primer sets were developed
from sequence analysis and after trials, two were chosen for investigation (Appendix A).
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The first primer set, MP-2 was chosen from DNA sequences in the 5' end of the
PI gene of M. pneumoniae in the published sequence of the gene:
MP-2 forward primer(MP-2F) 1228-1245 bases: 5' CCC AAG TGA AAC CAC CA 3'.
MP-2 reverse primer(MP-2R) 1698-1716 bases: 5' TGG TAC ATA TTC AAA CCA 3’. The
primers amplify a fragment of 488 base pairs (Appendix A).
A second primer set named MP-3 was chosen from DNA sequences which
flanked the sequence encoding the 13-amino acid binding domain of M. pneumoniae in the
published sequence of PI.
The MP-3 forward primer (MP-3F) sequence is: 5' CTC GCG CCT AAT ACT 3'.
The MP-3 reverse primer (MP-3R) sequence is: 5' AGG GTT CAC ACT TGC 3'. The
expected fragment size was 303 base pairs (Appendix A).
A third primer set, MP-V, was selected from the lower end of the sequence
between bases 374-832 of the CAP-21 gene insert described by Taylor et al, 1992. It
produces a fragment of 458 bp (Appendix B).
MP-V forward primer(MP-VF): 5' AGT TCG TCG TAT TGG AGG AGC T 3’
MP-V reverse primer(MP-VR): 5' TAA TCC CAC GTT CTT GCT CTT GAG CCA 3'.

PCR amplification parameters:
DNA from two virulent strains of M mycoides subsp. mycoides “SC” type
(PG1, Oremit) and DNA from M. pneumoniae were used initially in the search for the
possible presence of a cytadhesin gene in the former. Once DNA fragments from the
“putative” PI gene of PG1 and Oremit were amplified and the DNA sequences was
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obtained, DNA from the vaccinal strain T1 and “KH3J” and all other virulent strains were
analyzed in the same manner.

DNA template and primer concentrations:
DNA sample dilutions of 1:10,1:100, and primer concentration of 5,10 and 20
pM were tested and the optimum dilution of DNA and primer concentration established.
A 1:100 template DNA dilution and a primer concentration of 20 uM were chosen as the
optimum dilution and concentration for the experimentation.

PCR reaction mixture:
A 100 mi reaction mixture consisting of 267.5 pi of sterile H20 , 25 pi of each
primer, 80 pi of dNTP mix, 50 pi of 10X buffer, 2.5 pi of Taq polymerase for 5 PCR
reaction tubes, with 2 pi of the 1:100 template DNA sample dilution was used. The reaction
mixture amounts except for the template DNA were doubled for the 10 reaction mixture.
The tubes were covered with 70 pi mineral oil.
The reaction mixture was dispensed in 500 pi yellow PCR tubes (PGC
Scientifics, Gaithersburg, MD). Five or ten reaction tubes were set up: Tubes 1 and 2
contained 2 pi of the 1:100 DNA dilution of strain PG1; tubes 3 and 4 contained 2 pi of the
1:100 DNA dilution of strain Oremit; tubes 5 and 6 contained 2 pi of the 1:100 DNA
dilution of M. pneumoniae used as the positive control; tubes 7 and 8 contained 2 pi of the
1:100 DNA dilutions of strain KH3J; tubes 9 and 10 contained no DNA but received 2 pi
of sterile H20 and used as the negative control.
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The room the reaction mixture was prepared was separated from the PCR room
by two floors. The addition of the template DNA was performed in still another room.

Thermal cycling conditions:
PCR amplification of template DNA was carried out in a TCI thermal cycler
(Perkin Elmer Corp., Stafford, TX) using the following conditions: an initial cycle for 5
minutes at 94°C, followed by 45 cycles of 94°C for 2 minutes, 60°C for 30 seconds and
72°C for 1 minute and an additional cycle of 10 minutes at 72°C. The optimum conditions
established for the MP-2 and MP-3 primer sets in the amplification of their respective
fragments are: 20 ^M primer concentration (120 pg and 80 pg respectively for PG1 and T1
template DNA), and temperatures of 94°C denaturing, 60°C annealing and 72°C extending.
For the MP-V primer set, the optimum amplifying conditions are: 10 fjM primer
concentration (40 pg template DNA) and temperatures of 94°C denaturing, 58°C annealing
and 72 °C extending.

Gel electrophoresis of PCR products:
A volume of 50 ml of two percent agarose (1% Nusieve and 1% Seakem) in IX
TE (TRIS-EDTA pH 6.8) was used to make the gels for the detection of PCR products
(amplicons). Preparative gels for purification of DNA fragments to be used as DNA probes
were similarly prepared but with a volume of 75 ml. Twenty microliters (20 pi) of the PCR
amplification products together with the controls was placed in fresh tubes and 3 pi of gel
loading solution (Sigma, St.Louis, MO) added. This was pipeted into the gel wells and
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electrophoresed with a current of 80 volts for 1.5 hours. Eight and half (8.5 ul) microliters
of a 123 bp DNA ladder was used as a molecular weight marker to measure molecular
weights of the amplified fragments.
The gels were photographed on a FOTO/PREP I UV translluminator with a
Polaroid camera and film (Fotodyne, INC., New Berlin, Wisconsin).

Purification of PCR product for direct DNA cvcle sequencing:
Two methods were used to purify the PCR products for DNA sequencing:
Method 1: The amplified products of each strain (50 fA) were added together and
electrophoresed on a 3% Nusieve/Seakem preparative gel. The gel was run at 70 volts for
2.5 hours. Under UV light, the fragment was cut from the gel with a sterile scalpel and
placed in a dialysis bag containing 500 pi TE and the DNA was electroeluted by subjecting
the gel slice bag to 100 volts for 20-30 minutes (Ausubel et al, 1992).
The electroeluted DNA was concentrated with Microcon concentrations. DNA was equally
divided between two concentrates and spun at 2000 rpm for 15 minutes. Both tubes were
then inverted into the second set of Microcon tubes and spun for another 5 minutes at 4000
rpm in a microcentrifuge. Contents of the tubes were combined and the volume brought to
100 pi. Twenty microliters of the purified DNA fragment was electrophoresed to ascertain
the purity of the fragment.
Method 2: Ten microliters of each PCR product was added to 3 ul of dye and loaded on a
6% TBE (Polycramide MiniGel-Novex Corp, San Diego, CA). The gel was then stained
with 0.02% ethidium bromide solution for 15 minutes. DNA was separated at 150 volts for
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50 minutes. The desired band was then cut from the gel with a sterile scalpel, placed in 15
A sterile H20 in a sterile PCR tube and crushed with a pipette tip. The DNA was allowed
to elute from the gel for 24 hours. 2 A of this preparation was used for sequencing.

DNA sequencing:
A finol DNA sequencing kit (Promega Corp., Madison, WI) and direct
sequencing procedure developed in the laboratory of Dr. Diana Williams of the Gillis W.
Long Hansen’s Disease Center, Laboratory Research Branch in the Molecular Biology
Department at LSU School of Veterinary Medicine was used to obtain DNA sequences of
several regions of the “putative” PI-like gene of M. mycoides subsp. mycoides “SC” type
strains. Briefly, sequencing primers were labelled with gamma 32P as follows: one
microliter of primer (10 //M); three microliters of 32P dATP; one microliter of 10X
polykinase buffer; one and half microliters of T4 kinase (5 units); three and half microliters
of H:0 . A total volume of ten microliters. The reagents were gently mixed and incubated
at 37°C for 20 minutes. The primer was then heat inactivated at 90°C for 2 minutes and
drop pelleted by brief centrifugation in an ultra microcentrifuge and stored at -20°C until
used.
Three microliters of the template DNA (1:20 dilution); five microliters of 5X
sequencing buffer; one microliter of Taq polymerase; two microliters of the gamma 32P
labelled primer; eight microliters of H:0 , a total volume of 19 A- The reagents were gently
mixed by pipetting.
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A set of PCR tubes labelled GATC were placed in a row. Four microliters of
each dd/dNTP and three microliters of the sequencing reaction template mixture were
added to each of these tubes. The mixture was drop pelleted by brief centrifugation in an
ultra microcentrifuge.
The thermal cycling parameters were set as follows: The Thermal Cycler
(Model 9600 Geneamp PCR System, Perkin Elmer Cetus, Norwalk, Connecticut) was
preheated to 94°C. The reaction mixture was placed in the PCR and incubated at 94°C for
7 minutes. Then a thermocycle program of 94°C for 30 seconds, 60°C for 30 seconds and
70°C for 90 seconds was started for a total of 30 cycles. The cycling program was linked
to a soak program of 4°C. The tubes were then removed from the thermal cycler and three
microliters of stop solution dye added to each tube.
The sequencing gel solution (Gel Mix 6) was purchased from commercial
sources (Promega, Madison, WI) and the gel was cast according to manufacturer
instructions. The gel was pre-equilibrated for 2 hours at 70 °C before loading the samples.
Twenty four well combs were used and four microliters of the samples loaded into each
well. DNA was separated using 2200 volts for 1 hour and 30 minutes. After the run was
complete, the gel was placed on 3 mm membrane, baked at 80°C for 1 hour and exposed
to an X-ray film (X-OMAT AR, 35x43 cm, Eastman Kodak, Rochester, NY) for 16 hours.
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Results:
The primer set MP-2 amplified the expected 488 base pair fragment in M.
pneumoniae and in all the virulent strains of M. mycoides subsp. mycoides “SC” type and
the KH3J “vaccine strain” (Figure. 1). However, the primer set did not amplify the expected
fragment in the vaccine strain Tl. The KH3J vaccine strain is much more virulent than the
T1 strain and is no longer used as a vaccine strain and since it looked like it retained the
“putative” PI-like gene, we excluded it as a vaccine strain. DNA sequence analysis of all
the amplified fragments of the virulent strains of M. mycoides subsp. mycoides “SC” type
showed that their sequence was 100% homologous with that of the M. pneumoniae 488
base pair fragment amplified by the same primer set. The fragment was amplified at the
annealing temperatures of 55°C, 58°C and 60°C while the other temperature parameters
remained constant as described above.
Primer set MP-3 amplified the expected 303 base pair fragment in M.
pneumoniae and in all the virulent strains of M. mycoides subsp. mycoides “SC” type. This
primer set did not amplify the expected 303 base pair fragment in the vaccine strain Tl
(Figure 2 and 3). Sequencing of all the amplified fragments from virulent strains of M.
mycoides subsp. mycoides “SC” type showed that their sequence was almost 100%
homologous with a single base pair difference with the sequence of the 303 base pair
fragment of M. pneumoniae amplified by the same primer set (Figure 4). The codon
sequence of the 13-amino acid binding domain of M. pneumoniae within the 303 base pair
fragment was present exactly in the same order in all the virulent strains of M. mycoides
subsp. mycoides “SC” type as in M. pneumoniae (Figure 4).
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Figure 1. The Expected 488 bp Fragment Amplified by
the Primer Set MP-2. Lane 1 = Marker; Lane 2 =
Oremit; Lane3 = PG1; Lanes4 & 5 =T1; Lane6 =
negative control.
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To confirm the sequence homologies between M. pneumoniae and the virulent
strains o f M. mycoides subsp. mycoides “SC” Type in the amplified fragments was not the
result o f cross contamination, we tested the DNAs of the latter that were brought from
Kenya that had absolutely no contact with the DNAs from Britain or with M. pneumoniae
DNA. The sequence homology observed in the Kenyan DNA samples was exactly the same
as the one previously observed and described. To further investigate whether inhibitors of
PCR reactions was to blame for the inability to generate the 303 bp and 488 bp fragments
in the T1 strains, dilutions (1:10, 1:100, 1:1000, 1:2000 and 1:5000) of T1 DNA were
analyzed in the PCR and similar results were obtained. In addition, several T1 isolates were
amplified using the two primer sets and no strain gave the expected product (figure 3).
There were no detectable sequence differences between the different geographic strains
with respect to the 488 bp, and 303 bp fragments apart from the fact that The primers MP-2
and MP-3 were able to amplify the expected fragments in all the virulent strains of the
CBPP agent from all the geographic regions represented but did not amplify the fragments
in the T1 strains from Kenya, Tanzania and Ethiopia.
The third primer set MP-V was selected from the gene insert CAP-21 described
and sequenced by Taylor et al, 1992. This gene insert, to our knowledge, has nothing to do
with cytadherence and virulence. The primer set was selected from an area where all the
strains sequenced in that study had 100% homology with each other. This primer set was
chosen to investigate whether the T1 DNA was being inhibited and that the inhibition was
a reason for both the MP-2 and MP-3 primer sets not being able to amplify the expected
fragments in the vaccine strain T1. It was also selected to ascertain the assumed fact that
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a primer from a highly conserved region in the virulent M. mycoides cluster will also
identify the T1 strain. The MP-V primer set amplified the expected 458 base pair fragment
of the CAP-21 gene insert in all the virulent strains of M. mycoides subsp. mycoides “SC”
type (Figure 5). It also amplified the expected fragment of 458 base pairs in the vaccine
strain T1. The primer set did not amplify the 458 base pair fragment in M. pneumoniae and
in M. genitalium (Figure 5)..
A probe made from the 458 base pair CAP-21 fragment hybridized with the
virulent as well as the vaccine strain T1 but did not hybridize with genomic DNA from M.
pneumoniae and M. genitalium. Sequencing a portion of the 458 base pair fragment
amplified from T1 vaccine and virulent PG1 strains showed that the fragments were 100%
homologous at least in the first 160 bp that were sequenced. This sequence was similar to
the F38, Cal. Kid, Gladysdale, etc. strains of the M. mycoides cluster.
To investigate the possibility that the whole cytadherence gene may be missing
from the T1 strain, a comparison was made between the protein pattern of the virulent
strain PG1 and that of the vaccine strain T1. A 4-15% SDS-PAGE gradient gel and a 6%
SDS-PAGE were used (BIO-RAD) to electrophorese the proteins. Mycoplasma mycoides
subsp. mycoides “SC” type were grown as described above and centrifuged at 15,000 rpm
for 30 minutes in a JA-17 rotor. I ml of 70% ethanol was added to the pelleted cells and
kept at -20 °C until used. The ethanol was drained and the cells were resuspended in 1 ml
sterile water and the protein content determined by the Lowry method (Lowry et al, 1953).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

39

1

2

3

4

5

6

7

8

9

10

Figure 2. The Expected 303 bp Fragment Amplified by the Primer
Set MP-3. Lanes 1 & 10 = Marker; Lane 2 = Strain Oremit; Lane
3 = PG1; Lane4=Tl; Lane 5 =T1; Lane 6 & 7 = M. pneumoniae;
Lanes 8 & 9 = negative controls.

1

2

3

4

5

6

Figure 3. The Expected 303 bp Fragment Amplified by
the Primer Set MP-3. Lane 1 = Marker; Lane 2 = PG1;
Lane 3 = Tl-Kenya; Lane 4 = Tl-Kenya; Lane 5 = T lTanzania; Lane 6 = negative control.
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PG1 GCA ACG CCG CAA AGA TGA A£ G ACG ATG TTG AT**GOT ATT GTA
MP GCA ACG CCG CAA AGA TGA ATG ACG ATG TTG AT**GGT ATT GTA
CGC ACC CCA CTC GCT GAA CTG TTA GAT GGG** GAA GG ACA AC AGC CGC
ACC CCA CTC GCT GAA CTG TTA GAT GGG** GAA GG ACA AC AGC
PG1TGA CACT GGT CCA CA AAG CGT GAA GTT C AA GTC TCC
MP TGA CACT GGT CCA CA AAG CGT GAA GTT C AA GTC TCC
Figure 4. Comparison of the sequence of the PG1 strain of M. mycoides subsp.
mycoides “SC” type and that of M. pneumoniae (MP) in the amplified 303 bp
fragment.
Note: The two bases in which PG1 differs from MP are in bold and underlined. The 13amino acid binding domain sequence is bracketed by the astericks and underlined.
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Figure S.' The Expected 458 bp Fragment Amplified by
the Primer Set MP-V. Lane 1 = Marker; Lane 2 = M.
pneumoniae; Lane 3 = M. genitalium; Lane 4 = PG1;
Lane 5 = Oremit; Lane 6 = T 1; Lane 7 = negative
control.
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The suspension was diluted to give a final concentration of I mg protein per ml.
An equal volume of a 3% SDS was added, mixed, incubated at 37°C for 90 minutes and
then centrifuged at 15,000 rpm for 30 minutes at 4°C in a JA-17 rotor. Protein
concentration was again determined by the Lowry method. Alternatively, the SDS
solubilization step was omitted. The ethanol was drained out and the pellets resuspended
in sterile H20 . The protein content was determined by the Lowry method and dilutions of
1:10, and 1:100 directly loaded into the gel. Twenty five microliters of 1 parts sample and
2 parts sample buffer (Appendix C) were inoculated into each well and the gel placed in a
Mini Protean II Cell (BIO-RAD) and electrophoresed for 5-6 hours at 50 volts for the 420% SDS gels and for 1 hour and 30 minutes at 150 volts for the 6% gels. After very
promising results were seen in these precast gels, we decided to make longer gels with
longer running time and also add a stacking gel to the separation gel (Appendix C). This
gel was run at 150 volts for 7-8 hours. All gels were then immersed in a staining solution
(Appendix C) for 30 minutes (Bio-Rad recommendation). The gels were then removed from
the staining solution, immersed in destaining solution (Appendix C) and placed on an
orbital shaker until a clear background became visible. A picture of the gel was then taken
with a regular 35 mm camera and the pictures developed.
SDS PAGE analysis of cell lysates of virulent and T1 strains are shown in
figures 6 and 7. The protein gel patterns were too complex to distinguish whether the
cytadhesin gene was absent or altered in the T1 strains.
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Figure 6. Protein Pattern of the Virulent PG1 and the Vaccine T1 Strains of M.
mycoides Subspecies mycoides “SC” Type using 12% Separating Gel with a 4%
Stacking Gel: Lanes A, B, C, G, I = T1 Strain; Lanes D, E, F, H, J = PG1 Strain;
Lane K = High Molecular Weight Marker; Lane L = Low Molecular Weight Marker.
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Figure 7. Protein Pattern of the Virulent PG1 and the Vaccine T1 Strains of M
mycoides Subspecies mycoides “SC” Type using 7.5% Separating Gel with a 4%
Stacking Gel: Lanes A, C, E. G, = T1 Strain; Lanes B, D, F, H = PG1 Strain; Lane
1= High Molecular Weight Marker; Lane J = Low Molecular Weight Marker.
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The protein comparison showed that there are a number of proteins where the
two strains differ, high, medium and low molecular weight proteins but since we did not
know the molecular weight of the protein produced by the “putative” PI-like gene in this
organism, we could not point to any definitive protein as the cytadhesin protein produced
by the PI-like gene (Figures 6 & 7).
We established the maximum sensitivity of the primers at the following values:
1:106 dilution equivalent to 120 pg of PG1 and 80 pg of T1 template DNA. The specificity
was established by including M. Pneumoniae and M. genitalium 1:100 diluted template
DNA since the MP-V primer set is expected to amplify the 458 bp fragment in all the M.
mycoides strains but not in the former strains. The primer set MP-V did just that.
To establish the maximum specificity of the PCR assay, we useM. pneumoniae,
a human pathogen and M. genitalium another human pathogen. This was dictated by the
lack of availability of other cattle mycoplasmas for differentiation. The two human
pathogens were differentiated from the M. mycoides used in the study. Since M. mycoides
cross reacts with the other cattle mycoplasmas serologically and is probably
indistinguishible in cultures, it is necessary to have the isolates identified by other means
such chemical testing and use of monoclonal antibodies and determine specifically their
identify. With that knowledge, one can determine with certainty the specificy of the
polymerase chain reaction assay since it is known what samples are exactly being tested.
It will also be necessary to test vaccinated animals and animals that have never
been exposed to the agents and determine respectively the specificity of the assay regarding
the T1 vaccine strain in the vaccinated animals and specificity of those uninfected. Besides
it can very useful to use samples from known infected animals so that the epidemiological
and microbiological sensitivity and specificity can be determined.
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Discussion:
The cytadherence and cytotoxicity of M mycoides subsp. mycoides “SC” type
to both endothelial and epithelial cells has been described (Valdiviesco-Garcia et al, 1989).
However, genes or proteins involved in their pathogenicity and virulence have not been
previously described. Data presented in this study suggests that a cytadherence gene sim ilar
to the PI gene in M. pneumoniae and the PI40 inM genitalium is present in M. mycoides
subsp. mycoides “SC” type. The high degree of nucleic acid homology between M.
mycoides subsp. mycoides “SC” type and PI suggest a conserved cytadherence gene in
those pathogenic mycoplasmas that have tropism for the lung tissues. In addition, there
appears to be an absolute conservation of the 13-amino acid binding domain of this gene
product giving further evidence that the mechanism of epithelial cell adherence is similar
between these mycoplasma species. The observation that both PI gene primer sets did not
amplify the expected fragments in the vaccinal strain T1 is suggestive that the gene is
missing or has a major deletion or insertion of genetic material in this strain. We
demonstrated that the lack of amplification in the T1 DNA was not due to inhibition of
PCR reactions and that all T1 strains showed the same profile.
The inability to amplify the expected fragments in the T1 strain may have one
or more of the following possible explanations:
(1). Virulence genes are carried within the chromosomal DNA of the organism or
extrachromosomally by plasmids. Assuming that the cytadherence gene in M. mycoides
subsp. mycoides “SC” type is associated with a plasmid, then it is possible that the plasmid
may have been lost (ejected) during the attenuation process of the vaccine strain T1 and this
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The inability to amplify the expected fragments in the T1 strain may have one
or more of the following possible explanations:
(1). Virulence genes are carried within the chromosomal DNA of the organism or
extrachromosomally by plasmids. Assuming that the cytadherence gene in M. mycoides
subsp. mycoides “SC” type is associated with a plasmid, then it is possible that the plasmid
may have been lost (ejected) during the attenuation process of the vaccine strain T1 and this
may account for the inability of the primers MP-2 and MP-3 to amplify their respective
fragments in this strain. If this is the case, it is reasonable to assume that the plasmid is
present in all the virulent strains and prolonged storage has no effect on the plasmid where
in some other organisms it is ejected in prolonged storage. So far only two plasmids have
been identified in M. mycoides subsp. mycoides and none has been associated with
virulence (Dybvig et al, 1990).
(2). It is possible that mutations occurred in the cytadherence gene during attenuation and
that the gene product may have not been produced or a different product unable to perform
the function of cytadherence may have been produced.
(3). The entire cytadherence gene may have been deleted during the attenuation process.
Either scenario (2 or 3) may explain the molecular basis for the difference in virulence and
pathogenicity between the virulent wild strains and the vaccinal T1 strain. The KH3J
behaved much the same as the virulent strains producing the expected fragments from both
MP-2 and MP-3. It is known that this strain has been observed to be much more pathogenic
than the T1 and slightly less than the wild strains. Because of this virulence, its use was
abandoned in favor of the T1 strain used only in Africa. This study may have given the
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molecular basis for its sustained virulence suggesting that it may not have lost the
cytadherence gene at all.
(4). A major insertion mat have been added to the “putative” PI-like gene in the T1 strain
and this may have affected the gene product.
Because the PI gene did not appear to be intact in the T1 strain, we attempted
to determine if the “putative” PI-like product was produced in this strain by comparing the
protein profiles of the virulent PG1 and the vaccine T1 strains (Figures 6 & 7).
The fact that one of the primers (MP-V) clearly differentiated M. mycoides
subsp. mycoides “SC” type from M. pneumoniae and M. genitalium (closely related with
respect to the cytadherence gene and taxonomically) may be very useful in the diagnosis
of this organism from the other mycoplasmas that affect the same host and that otherwise
pose difficulty in differentiation on the basis of serological tests because of cross reactions
or on the basis of microbiological tests because of the inability of most laboratories in
developing as well as in developed countries to perform specialized tests for identification,
partly due to the lack of interest in this economically important pathogen. The inability of
the MP-V primer set to amplify the 458 bp fragment in M. pneumoniae and M. genitalium
suggested that the primer set MP-V recognizes only the M. mycoides cluster and does not
recognize its close relatives M. pneumoniae and M. genitalium. On the other hand, the
amplification of the 458 bp fragment in the T1 strain indicated that the T1 DNA was
amplifiable and no inhibiting factors were responsible for the failure of the MP-2 and MP-3
to amplify their respective fragments in this strain.
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Because, the MP-2 and MP-3 primers are able to differentiate the virulent
strains of the organism from the vaccine strain T1 may finally put to rest whether infection
is due or not to the T1 strain in immunosuppressed animals that have been vaccinated with
this strain and subsequently became infected. This ability of the two primers may be
employed as a rapid method of differentiation in cases where viable organisms of M.
mycoides subsp. mycoides are isolated from Somali cattle exports and elsewhere. If vaccine
strain DNA is detected it will be further proof that the animals had been vaccinated and that
any CBPP-like symptoms seen in these animals should be ascribed to diseases other than
CBPP. In addition, all primer sets MP-2, MP-3 and MP-V may become very useful in
determining whether ticks and fleas transmit the organism from infected animals to
susceptible ones through their ability to identify whether the isolated organisms possess or
lack the cytadhesin gene. Furthermore, the primer set MP-V may be employed in
determining if any member of the M. mycoides cluster and particularly the “SC” type
affects the wildlife population of east Africa, an important issue in the control of CBPP. All
three primer sets may be used to study outbreaks of CBPP where organisms isolated at the
beginning of an outbreak are more pathogenic than those isolated at the end of it.
Specifically with MP-2 and MP-3, it can be studied whether the organisms isolated at the
end of the outbreak can be classified as virulent forms or as attenuated forms and show
similar pattern with the vaccine strain Tl.
Both primers MP-2 and MP-3 may be extremely useful in anticipating
outbreaks o f the disease by detecting possibly chronic carriers and animals incubating the
organism, important circumstances essential in initiating outbreaks. While these primers
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may provide

an early detection method for the disease agent, effective outbreak

management, surveillance and proactive vaccination are some of the ingredients needed for
the efficient control and eventual eradication of CBPP.
The full characterization of the entire gene should be done in a future study. The
information gained may be useful to define the mechanism of attenuation and to
manufacture specific primers to differentiate this important cattle pathogen not only from
the T1 strain but also from the other members of the M. mycoides cluster. The whole gene
can again be used to probe for homologous sequences in a search for other genes involved
in cytadherence. The rationale for this later undertaking is based on the fact that in both M.
pneumoniae and M. genitalium, smaller cytadherence genes were identified that have
homologous sequences respectively with the PI and PI40 genes.
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Chapter 3. Development of a Multiplex PCR Assay for Detection of M. mycoides
subsp. mycoides “SC” Type DNA from Purified DNA Samples and from Crude
Field Specimen

Introduction:
Contagious bovine pleuropneumonia (CBPP) is a socioeconomically important
disease in Somalia where it is endemic. Since the economy of the country is totally
dependent on the livestock sector, the control and eradication of CBPP is socially and
economically desirable particularly in animals destined for export from which more than
80% of the country’s foreign currency earnings come from. Obstacles to reaching the
above objective are many. Among them:
a. Funding of the programs. The reliance of donor funding for such socioeconomically
important programs has been a total disaster because governments do not allocate funding
for the continuance of the program after the donor funding has run out with the inevitable
recurrence of a disease that was once under control.
b. Many important aspects of the disease essential for a successful control are not known
or have received scant research attention. One such aspect is whether the vaccine strain T1
used extensively in vaccination campaigns reacquires its virulence in conditions where an
animal is subjected to stressing conditions such as transportation, or other infections and
infestations. This aspect is very important in that Mycoplasma mycoides subsp. mycoides
“SC” Type has been isolated from exported animals previously vaccinated with T1 that
have come down with CBPP-like symptoms en route to or on arrival at their destination.
One of the difficulties in investigating these incidents has been the problem of identifying
the isolated organism as a virulent strain or as a T1 vaccine strain.
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Since traditional methods of detection and identification of M. mycoides subsp.
mycoides “SC” type such as serology can not differentiate the virulent strains from the
vaccine strain T1 through the antibody response they provoke, nor are the other
microbiological methods able to differentiate the strains from each other, it became
necessary to investigate whether a genetically-based method of identification and
differentiation could potentially detect differences among these strains. Data obtained in
the first part of this research suggested that this was possible using sequences of the
“putative” PI-like gene and CAP-21 gene insert.
Since the T1 strain can usually be isolated from an animal that comes down
with a debilitating infection within three months of being vaccinated with the strain, the
export animals that come down with a disease are expected to have viable T1 strain in their
respiratory canal and particularly in lung exudate if the disease brings about an
inflammation of the lungs. Besides, in any outbreak of CBPP the etiologic agent is found
in abundance in the lung exudate produced by the inflammation of the lungs and the pleura.
Therefore lung exudate from animals suspected of having CBPP were used in this analysis.
We also tested with the PCR assay the lung homogenate and nasal swabs from the same
animals.
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Materials and methods:
With three primer sets, one of which amplifies a 458 bp fragment in virulent
strains as well as in the T1 strain of M. mycoides subsp. mycoides “SC” Type and the others
amplifying their respective fragments only in the virulent strains of the organism, it was
decided to develop a multiplex PCR assay using the MP-3 primer set that amplifies a 303
bp fragment in the virulent strains and the MP-V primer which amplifies the 458 bp
fragment in the vaccine strain T1 as well as the virulent strains. The multiplex PCR assay
was expected to amplify two fragments from all the virulent strains (303 bp and 458 bp)
and one fragment in the vaccine strain T1 (458 bp) thus obtaining an assay that can
differentiate the two strains in one amplification process. We determined the optimum
amplification parameters: each reaction tube receiving 10 A of the forward and 10 A of the
reverse of a 20 ^M MP-3 primer concentration and 2-3 A of the forward and 2-3 tA of the
reverse of a 3-5 mM MP-V primer concentration. The temperature conditions established
were: 94°C denaturing, 58°C annealing and 72°C extending. We then used this assay to test
crudely prepared samples from Kenya.

Sensitivity and specificity determination of the PCR assay using the known strain
DNA’s (virulent strains and vaccine strain Tl):
The purified DNA samples were used in the following forms: 1:10
(PGl=120Mg; Tl=80/zg), 1:100 (PGl=12Mg; Tl=8^g), 1:1000 (PGl=1200ng; Tl=800ng),
1:10,000 (PGl=120ng; Tl=80ng), 1:100,000 (PGl=l2ng; Tl=8ng) and 1:1,000,000
(PG1=120 pg; Tl=80 pg) dilutions of PG1 and T l. A 10 reaction tube mixture was

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

54
prepared as follows: 535 A sterile H ,0, 160 (A dNTP mix (125 ^1 of each dNTP added to
500 fA sterile H20), 5 /A Taq polymerase and 100 /A of 10X buffer containing MgCU were
added together, mixed and 90 A dispensed into each of 10 PCR reaction tubes. 10 A of the
forward and 10 A of the reverse of primer set MP-3 at a concentration o f 20 a*M were first
added to each tube, then 2 A of the forward and 2 A of the reverse primer set MP-V at a
concentration of 3 //M added into each reaction tube. 70 A of mineral oil was overlaid in
each tube and the PCR run at 94°C denaturing, 58°C annealing and 72°C extending for 45
cycles with an additional 10 minute extension at the end of the cycles. The ninth reaction
tube contained M. pneumoniae or M. genitalium DNA while the tenth tube contained no
DNA. Both reaction tubes were included as controls. The PCR product was then processed
as described before.

Samples:
Cultures: Known laboratory strains of both the virulent and the vaccine Tl
strains were grown and DNA extracted as described in section 2. DNA samples of the
virulent strains Oremit and PG1 and of the vaccine strain Tl were used to test the
sensitivity and specificity of the PCR assay.
Tissue Samples: A total of 62 field samples that were collected from field
outbreaks of CBPP-like disease syndrome were chosen. Some of the samples were
generously provided by the Muguga laboratory and were from outbreaks between 1980 and
1990. The rest of the samples were collected from suspected outbreaks in 1994. The
samples were from diseased animals whose recent history included vaccination against
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CBPP with the Tl strain. Each sample and their respective serums were tested serologically
and culturally when available. The samples consisted of lung tissue, lung exudate and nasal
swabs and were processed as follows:
(1). Lung tissue: 5 grams of lung tissue were minced and homogenized in 5-10 ml sterile
water. Another 5-10 ml sterile water was added to the homogenate if it looked dry. The
homogenate was then centrifuged at 3000 rpm for 10 minutes and the supernatant collected
in a fresh sterile 2 mi centrifuge tube and centrifuged at 15,000 rpm for 20-30 minutes in
a JA-17 rotor. The supernatant was drained off and 1 ml of 70% ethanol added to the pellet
and kept at -20°C. When ready to be used, the samples were centrifuged at 10,000 rpm for
10 minutes in a microcentrifuge and the ethanol drained out. The pellet was then
resuspended in 200 ^1TE and freeze-boiled 3 times for 5 minutes each. 10 ^1 of the lysate
was then used in the PCR assay.
(2). Nasal swabs: The end of the swab was broken off and immersed in 1 ml of 10%
sputalyzine and let sit for 15 minutes at room temperature and vortex mixed for 30 seconds.
The swab was removed and the sample left to stand for 5 minutes. The sample was then
centrifuged for 10 minutes at 10,000 rpm in a microcentrifuge and resuspended in 200 iA
sterile water. 100 (A of the suspension was dropped into a 2 ml microcentrifuge tube and
1 ml of 70% ethanol added. The other 100 /A was freeze-boiled 3 times for 5 minutes each
and both samples kept at -20 °C until used. Before storage, both sample types were cultured
for viability. None was found. Before use, the ethanol-fixed portion was freeze-boiled 3
times for 5 minutes each in the presence of TE.
(3). Lung exudate: 5-10 ml of the lung exudate was centrifuged at 15,000 rpm for 20-30
minutes in a JA-17 centrifuge. The supernatant was drained and 1 ml of 70% ethanol added
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to the pellet and stored at -20 8C. Before use, the samples were centrifuged at 10,000 rpm
for 10 minutes in a microcentrifuge and the ethanol drained off. The pellets were then
resuspended in 200 (A TE and freeze-boiled 3 times for 5 minutes each. 10 [A of the lysate
were used in the PCR assay.
The 62 lung exudate samples were run with the assay 20 samples at a time, 18
of the field samples. The 19th tube contained M. pneumoniae or M. genitalium DNA as a
known control and the 20th tube contained no DNA at all and was used as a negative
control. The remaining 8 samples were run in the 4th PCR assay with the two controls. In
all four runs of the assay, the same thermal cycler was used at the same conditions
described above. Dilutions of neat, 1:10 and 1:100 of each sample was tested and results
recorded as positive or negative regardless of the dilution factor.
Field samples (lung exudate) were collected from previously vaccinated animals
in a suspected CBPP-like disease outbreak. However, we selected only those that had serum
for serologic testing and one or more of the other specimen for culturing. These results
were recorded. Two serological tests were performed: The rapid slide agglutination test
described by Lindley, 1958 (Lindley, 1958) and the ELISA test described by Kalif, 1992
(Kalif, 1992). The culture was done on solid DE media as described by Provost et al, 1987
(Provost et al, 1992). The lung homogenate and nasal swabs were also tested with the
assay.
Optimum PCR cycling parameters: 94°C danaturing, 58°C annealing and 72°C
extension for 45 cycles. At the end of the cycles, a further 10 minute extension was added.
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PCR amplification of the field samples:
Characterization of the multiplex PCR assay for differentiation of virulent and
vaccine strains of M. mycoides subsp. mycoides “SC” type in field specimen was
accomplished using the following protocol: 10 A of the crude specimen preparations were
added to each reaction tube and the template DNA was amplified using the optimal
conditions for the multiplex PCR described above. In this assay, 20 reaction tubes were set
u p , eighteen of them containing samples, and the other two used as positive and negative
controls. Twenty reactions were prepared as a stock: 1070 A sterile H20 , 320 A dNTP mix.
10 (A Amplitaq and 200 (A of the 10X buffer. The reagents were mixed and 90 A- dispensed
into each reaction tube. Then 10 A of the forward and 10 A of the reverse of the primer set
MP-3 at 20

concentration was added into each reaction tube as well as 2 A of the

forward and 2 A of the reverse of the primer set MP-V at 3 a*M concentration. Again the
reagents were mixed and 70 A of mineral oil overlaid in each reaction tube. 10 ^1 of the
sample was then dropped at the bottom of the tube and mixed. All 20 reaction tubes were
put in the thermal cycler and run as described using the optimum cycling parameters
described above. After the PCR cycles were completed, 18 A of the PCR product was
mixed with 3 A of a gel loading solution and loaded on to a 2% agarose gel (1% Seakem
and 1% Nusieve) in the presence of 0.01% ethidium bromide and electrophoresed at 80
volts for I hour and 30 minutes in TAE buffer. A photograph of the gel was taken using
UV translluminator and a Polaroid camera.
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Results:
Sensitivity and specificity of the PCR assay:
To measure the sensitivity of the primers, we determined the least amount of
template DNA that the primers can amplify their respective fragments from known virulent
M. mycoides subsp. mycoides “SC” Type DNA and from the vaccinal T l strain. The
sensitivity of the primers was established at the following values: PG1=120 pg and Tl=80
pg. To measure their specificity, we included in the testing DNA samples at dilutions of
1:100 from M. pneumoniae and M. genitalium, both human pathogens. We had no other
cattle Mycoplasmas to test the specificity of the PCR assay.
The multiplex PCR assay successfully differentiated the virulent strains of M.
Mycoides subsp. mycoides “SC” Type from the vaccine Tl strain by amplifying 2
fragments, the 303 bp and the 458 bp in the virulent strains and only one fragment, the 458
bp in the vaccine Tl strain (Figure 8). The assay also amplified the 303 bp fragment in M.
pneumoniae and M. genitalium but did not amplify the 458 bp fragment in both organisms
(Figure 9).
A comparison of a 160 bp sequence between the virulent PG1 strain and the
vaccine Tl strain in the 458 bp fragment produced by the MP-V primer set revealed that
they were similar and when compared to other sequenced strains, it showed that it was
similar with the sequences of Gladysdale and F38 and M capricolum strains published by
Taylor et al 1992.
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Figure 8. Multiplex PCR with Primers MP-3 and MPV. Lane 1 = Marker; Lanes 2 ,3 , & 4 = PG1; Lanes 5,
6, & 7 = T1; Lane 8 = negative control.
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Figure 9. Multiplex PCR with Primers MP-3 and MPV. Lanes 1 & 11 = Marker; Lanes 2 = M. pneumoniae;
Lane 3,4, & 5 = PG l; Lane 6 = M. genitalium; Lanes
7,8, & 9 = Oremit; Lane 10 = T l.
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Multiplex PCR assay of the field samples:
Of the 62 samples , 59 were serologically positive for M. mycoides subsp.
mycoides “SC” Type antibodies. The remaining 3 samples were negative and were included
as known negative samples. 11 samples that were seropositive were also culture positive
for the vaccine Tl strain. The multiplex PCR assay detected 19 positive samples giving the
single fragment profile of the Tl strain DNA (Figure 10 and Table 1).
The PCR assay produced the 458 bp fragment in all 19 samples at dilutions of
neat, 1:10, 1:100. Of these 19 specimen, 11 were culture positive for M. mycoides subsp.
mycoides “SC” type. Pure cultures from the 11 culture positive samples were previously
inoculated by intubation into susceptible cattle in Kenya and were found not to cause
clinical CBPP although antibodies against the organism were detected after 4 weeks
(Personal communication from Dr. Mugera of the Muguga Laboratory).
Of the nineteen (19) samples that were positive for Tl vaccine strain in the
multiplex Polymerase chain reaction (PCR) assay, all were from different herds and none
has any connection with the others. Five of those positive samples are shown in figure 10.
The rest have not been displayed because of the similarities of the pattern of their
manifestation.
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1 2 3 4 5 6 7 8 9 10 11 12

Figure 10. 5 of the 19 field specimens detected by the
multiplex PCR assay as T1 strains.
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Table 1. Comparison of culture, serology and PCR of the lung exudate samples from
cattle of CBPP-suspect herds in Kenya

Positive

Negative

Total

Serology

59

3

Culture

11

51

62

PCR

19

43

62

62

Table 2. Comparison of serology and culture of field samples

Serology
Positive
Culture

Negative

Total

Positive

11

0

11

Negative

48

3

51

Total

59

3

62
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Table 3. Comparison of culture and PCR of the field samples

Culture
Positive
PCR

Negative

Total

Positive

11

8

19

Negative

0

43

43

Total

11

51

62

Table 4. Comparison of serology and PCR of the field samples

Serology
Positive

Negative

Total

Positive

19

0

19

Negative

40

3

43

Total

59

3

62

Note: The serological tests used to test the serum samples were the rapid slide agglutination
test and ELISA. Only animals whose serums showed positive on both tests were included
in the samples that were tested with the PCR assay. The culturing of the samples was done
on solid DE media and the samples cultured were those of the lung exudate. Only animals
whose serum samples as well as their lung exudate samples were available were included
in the PCR assay test. The Multiplex PCR assay was also performed on the lung
homogenate and nasal swabs with similar results.
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Discussion:
Both the culture and serological test did not, however, go beyond classifying
the sample results as possible M. mycoides subsp, mycoides “SC” Type positive since both
non-specific reactions due to a possible presence of an IgG-FC receptor on the organism
and cross-reactions due to other bovine mycoplasmal infections can be responsible and
since on the basis of culture characteristics, it is difficult to differentiate the various bovine
mycoplasmas from each other and between the M. mycoides cluster.
Having no idea of how much M. mycoides subsp. mycoides “SC” Type DNA
there was in each sample if any, we relied on the fact that if there was any sample that
became positive in the PCR assay, we run that sample as neat, 1:10 and 1:100, 1:1000,
i

1:10000, 1:100,000 and 1:1,000,000 dilutions to judge the amount of DNA present in the
sample. The inclusion of the primer set MP-V in the multiplex PCR assay also set the
specificity of the assay by not amplifying the 458 bp fragment in M. pneumoniae and M
genitalium. The non-amplification of the 458 bp fragment in M. pneumoniae and M.
genitalium established the specificity of the assay.
Due to the inaccuracies of serological tests caused by both non-specific
reactions and cross-reactions and their lack of sensitivity to carrier animals and animals
incubating the organism, the multiplex PCR assay may be used as a tool to identify virulent
M. mycoides subsp. mycoides “SC” type in herds. The difficulty in isolating M. mycoides
from field samples through culturing especially in chronic carriers and animals incubating
the disease may also make the PCR assay very valuable in predicting possible outbreaks
and thus making possible the institution of contingency plans for prevention and outbreak
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containment. Furthermore, the assay may also be useful in detecting the organism from
decomposing animals so that a correct diagnosis of the cause of death can be determined.
Since we reasonably expected more samples to be positive for the T1 strain, the
detection of only 19 of the 59 samples that were serologically positive may mean that most
of the animals were vaccinated long before (more than 3 months) the sampling day and that
all viable T1 strain organisms were cleared from the body. No records were available to
substantiate this hypothesis.
In specimens which were culture and PCR negative yet serologically positive,
both the rapid slide agglutination and the ELISA tests may have been detecting cross
reactive antibodies produced as a result of an infection with other mycoplasma-induced
diseases. It is also possible that reaction was due to a non-specific reaction which is
common in Mycoplasma serology tests (Kalif, 1992) or detecting waning antibodies from
a past infection or vaccination or that it may have been due to a non-specific reaction and
that the investigators knowing beforehand that the samples were from an outbreak of
CBPP-like disease may have classified it hastily as positive at the sight of a reaction
without further verification by measuring the amount of antibody they were “detecting”.
The consequences of hasty judgement can have important economic implications especially
in Somalia where if such an animal turns up in an export shipment, the whole shipment is
abandoned and the herd from which that animal came from (if known) will never get
another chance to sell their animals for the export market.
Given the fact that the samples were from animals in the middle of a suspected
CBPP outbreak when the etiologic agent can be found in abundance in the lung tissue, lung
exudate and is shed in large amounts with the nasal droplets, only a combined 30 samples
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were positive in culture and in the PCR assay is suggestive of a misdiagnosed outbreak.
Besides, if this was a real CBPP outbreak, it is surprising at this early stage of an outbreak
to detect antibodies. It is the opinion of this investigator that the serological test was
actually detecting the antibodies produced against the previous vaccination or a past natural
infection.
All culture positive specimens were PCR positive for M. mycoides subsp.
mycoides “SC” type. In addition, 8 culture negative were PCR positive. Since the
sensitivity of this assay was found to be a detection of less than 1000 organisms, it is
possible that the assay can detect that number of organisms in the presence of heavy
contamination and decomposition where it may be impossible to isolate M. mycoides subsp.
mycoides “SC” Type culturally and these few organisms are not enough in number to
provoke a detectable antibody titer.
Some plausible explanations for the 19 samples detected by the PCR assay
being T1 vaccine strains are:
a. The stress brought on by the journey may have given a few viable T1 organisms from
the previous vaccination a chance to multiply again.
b. The suspected CBPP-like disease may have in fact been another infectious disease and
that it may have weakened the animal that still harbored viable Tl organisms and thus have
given the organism a chance to multiply.
C. The animal may have been immunosuppressed by such diseases as trypanosomiasis,
dermatophytosis, etc. and that the vaccine strain from the vaccination may have remained
active multiplying in the animal.
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Since no virulent strain DNA was detected, it is probable that the initial CBPP
diagnosis was a mistaken one and that the outbreaks may actually have been due to such
diseases as pasteurellosis. Outbreaks of pasteurellosis are frequently mistakenly diagnosed
clinically as CBPP and visa versa (personal field observation). It is important to understand
that in Somalia and in other African countries that CBPP and Pasteurellosis are almost
always associated with each other and that differential diagnosis is important using
serology before any conclusions are reached about the nature of the outbreak.
It is however necessary to point out that this assay should be employed in
especial situations such as disputes arising from export animals and in areas where the
disease has been declared eradicated and unclassifiable mycoplasmas by conventional
methods are isolated.
While primers that can specifically detect M. mycoides subsp. mycoides DNA
have been described, a PCR assay that can actually differentiate the virulent strains from
the vaccine strain T1 has not been previously described. The advantages of having such an
assay are:
(I). In field investigations where animals become infected after having been vaccinated:
This is especially troublesome. It has been observed in animals infected with other
infectious diseases and particularly with trypanosomiasis and other immunosuppressive
diseases. The assay can verify from 120 pg of DNA for virulent strains and 80 pg of DNA
for the T1 vaccine strain whether the clinical infections were due to the vaccine strain T1
or a virulent strain or whether the outbreak was wrongly attributed to CBPP but was in fact
another CBPP-like syndrome.
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(2). When exported animals are shown to have become diseased en route or upon arrival
at their destination with a CBPP-like disease and to be excreting the organism culturally,
the assay will be definitive in determining whether the culture isolates are in fact a virulent
strain or the T1 vaccine strain.
(3). Vaccination against CBPP in animals incubating the disease or are in the subacute
phase of the disease where serological and cultural detection are impossible, usually
precipitates the disease fast, especially in outbreaks where some animals within the herd
have already shown signs of the disease. The practice in Somalia of vaccinating all animals
intended for export against CBPP may just bring about the above scenario. Under these
circumstances, the PCR assay may be employed in screening all export-oriented animals
i

for the presence of M. mycoides subsp. mycoides “SC” type DNA from lung exudates
clinically taken from the live animal. Any animal that tests positive can then be excluded
from vaccination and thus from export and all appropriate actions can be taken against the
herd from which the animal came if it is known.
(4). It takes few hours to obtain the results of the PCR assay when it takes days and
sometimes weeks in cases of culturing to obtain results. In outbreak situations, time is a
decisive factor. The sooner a definitive diagnosis is made, the faster preventive and
containment measures can be taken.
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Some of the limitations of the multiplex PCR assay are:
(1). That it has limited use as a field diagnostic tool since it must be done in a wellequipped laboratory and have well-trained technicians to perform it.
(2). That we have not fully determined the specificity of the assay by testing it against other
cattle mycoplasmas. These were not available at the time of this study.
The relatively high sensitivity and potential specificity of the PCR assay may
have an impact on the export cattle in Somalia when disputes arise about mycoplasma
isolations. In the case of the MP-V primer, a 160 bp sequence analysis comparison of the
virulent Oremit strain and the vaccine T1 strain in the 458 fragment which the primer
amplified in both strains revealed that they were similar and when compared to the
sequences of the strains in Taylor et al, 1992 publication, it showed that both were similar
to the strains Gladysdale, M. capricolum and F38. This fact may give this primer set a
particular significance as specific for members of the M. mycoides cluster. Both the T1 and
PG1 strains had identical sequence in this region when we compared the sequence of the
458 bp fragment from both strains.
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Chapter 4. Guidelines for Collecting Representative Samples from the Nomadic
Population of Somalia

Introduction:
Since the economy of Somalia is largely dependent on the export of live
animals and given the fact that these animals are vaccinated against CBPP prior to being
exported, it has become problematic convincing the importing countries that any antibodies
against M mycoides subsp. mycoides “SC” Type or viable organisms detected in these
animals are a result of the vaccination with the T1 strain and not a result of natural infection
with the virulent strain. What is therefore needed is to conduct a study in Somalia to assess
the duration of vaccinal antibodies and the duration that T1 DNA can be detected from
vaccinated animals. In such a study, we need to select representative herds and sample
them regularly over a period of not less than 1 year utilizing serum samples, nasal and ear
swabs, and most important, lung exudate samples obtained by inserting a sterile needle
between the 5th and 6th intercoastal space and drawing about 5 ml of fluid. This study will
also be utilized to establish the epidemiological sensitivity and specificity of the assay by
collecting samples from the vaccinated animals, known naturally infected animals and
animals that has never been exposed to infection or vaccination and test them with the
assay. Establishing the specificity of the assay will depend on the application. If the
application is to detect vaccine strains, then known naturrally infected animals can be used
for specificity. If the application is for confirmation of an infection, then specificity can be
established by including animals that have never been exposed to the disease. The sample
size can be determined by first surveying the animals to find the proportion with M.
70
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mycoides antibodies or DNA then establishing the required preicision in 95% of the time,
the sample size can be calculated:
n=4pq/L2 where n=sample size, q=l-p and L=the required precision (Martin et al, 1987).
Knowing the problems that can hinder studies in nomadic populations, a
special consideration will be given to the problems and obstacles that can be encountered
in collecting samples from the nomadic population of Somalia. This will include some
insights from the author’s long experience in dealing with a nomadic population.

The Nomadic population in general:
Nomads constitute about 70% of Somalia’s human population and own more
than 95% of the country’s livestock estimated at around 42 million head (Livestock stats,
MLFR, 1 988-89-After 7 years of civil war, my assumption is that at least 10 million
animals may have perished from diseases, predators both human and animals). The rest of
the livestock are owned by sedentary crop fanners who live in small farming communities
in the inter-riverine area of the country.
This nomadic population and their livestock are characterized by constant
seasonal movements in search of grazing and water. This movement involves crossing
regional boundaries within the country and across international borders into neighboring
countries. In the 2 dry seasons (July-September; January-March), almost the whole
livestock population in the south congregates in the inter-riverine area and around the
boreholes both in the south and north-central parts. In the 2 rainy seasons (April-June;
October-December), the livestock disburses into the interior of the country. Although the
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nomads utilize the animals for their milk, meat and transportation, the production system
is not market-oriented. This reduces their dependence on markets and accounts for their
inaccessibility during much of the year.

Obstacles to sampling the Somali nomads:
(1). A major problem is that of tracking and locating the nomads and their herds especially
during the 2 rainy seasons when they disperse into the interior of the country and where
muddy roads limit accessibility. This is a serious setback for studies that require year-round
sampling.
(2). Overcoming the mistrust of the nomads in relation to government-sponsored studies.
This perceived mistrust is reinforced by the constant lack of feedback to the nomads about
the findings of previous studies, either of information or benefits.
(3). Obtaining the necessary funds and equipment. Somali politicians have always been
indifferent to research.
(4). Locating sentinel herds as they move through the interior and across international
boundaries.
(5). If the study requires vaccinations such as the one we propose here, one of the major
obstacles would be in maintaining the Cold chain infrastructure because of the lack of
mobile field laboratories equipped with refrigerators and freezers.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

73

General factors to be considered in sampling the nomadic livestock
population of Somalia before starting the vaccination study:
(1). The lack of knowledge of the breed, age and sex composition of the Somali livestock
population.
(2). There is a significant difference in the prevalence of cattle diseases between the
Southern and Central-Northern parts of the country. This is particularly true in the
prevalence of such chronic diseases as trypanosomiasis. It is known that the response to
vaccination between animals infected with trypanosomiasis, dermatophytosis, etc., and
those not affected is significantly different (Chima et ai, 1986; Osiyemi et al, 1985). In
Somalia, at one point it was estimated that about 8% of cattle in the south are infected with
trypanosomiasis while the prevalence in the north was considered to be zero.
(3). Grazing and watering opportunities are not evenly distributed across the country. These
are more abundant in the south than in the north-central parts. The state of nutrition is
known to have an impact on an animal’s ability to adequately respond to vaccination.
(4). The optimum time of the year to vaccinate the animals for the study is another issue
that requires much attention. It is known that vaccination stresses livestock. Vaccinating
animals in the dry season when they are already stressed by movement and poor grazing
can have unforeseen consequences. If the animals are vaccinated at the beginning of the
rainy seasons, finding them for subsequent sampling is going to be difficult because of their
dispersal into the inaccessible interior of the country.
(5). Animals under the age of two years and those over the age of ten years should be
excluded from the study because the former are still passively immune to CBPP and the
latter are not exported.
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Selection of the study herds:
Since herds in the south and central-north parts of the country will be different
in many ways, it will be necessary to select a random sample of herds in both parts and
estimate the herd composition in terms of breed, age, sex, disease status, etc.. Based on that
information, then we can select the herds for the study. The sample analysis should be
separate for the two parts of the country so that we will have more precision in generalizing
the results from the southern herds to the south and vice versa.
Almost all the watering points in the inter-riverine area and almost all the
boreholes in the country where animals congregate in the dry seasons for water are known.
Constructing a list of them is quite possible thus creating a sampling frame. Clustering or
stratifying the sampling frame on a regional basis is also feasible and probably desirable.
A random sample of herds from each strata can then be selected. The herds can then be
systematically sampled for the animals to be included in the study.
Finally, sampling of identified animals in the selected herds on a monthly basis
might be the best approach statistically and also in minimizing the cost o f the study.

Suggested solutions:
(1). Select sentinel herds on the basis of accessibility and status of disease under
investigation.
(2). There are things that an investigator can do to get the cooperation o f the nomads in
studies that require repeated sampling. Exploiting the fact that nomads revere their
community religious leaders and in all instances heed their advice. Approaching these
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religious leaders has been successfully used by the author in previous studies. Another
successful approach the author had employed is to provide drugs and treat the sick animals
of the nomads participating in the study free of charge. Also providing individual feedback
goes a long way in establishing trust between owners and the investigator.
(3). Availability of mobile laboratories, radios and Global Positioning Satellite (GPS)
capability can make locating, sampling and testing of nomadic herds much more easier and
less expensive.
(4). Initial pilot study may be useful in determining not only the herd composition of
Somali cattle but also in collecting some data on movement, production, reproduction, etc..
It is also tempting to collect the data from sedentary herds especially if it is a rainy season
but one has to keep in mind that any data collected from such herds is in no way
representative of the Somali nomadic livestock population. This will give the investigators
the opportunity to sort out initial problems and to get a feel of the more complex later
situation.
(5). Institute a campaign of mass education of the nomadic population so that the benefits
and side effects of vaccinating their animals can be explained by professionals. This will
also help get the professionals to know more about the nomads and their life styles so that
they and the professionals can work in harmony.
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Summary and conclusions:
Summary:
Two primer sets (MP-2 and MP-3) were designed from a region o f the cytadherence
gene PI of M. pneumoniae and the P140 of M. genitalium share absolute homology and
used to detect homologous sequences in M. mycoides subsp. mycoides “SC” Type, the
etiological agent of Contagious Bovine Pleupneumonia (CBPP). Both primer sets amplified
the expected fragments in all the virulent strains of the organism, a 488 bp fragment by MP2 and a 303 bp fragment by MP-3. The two primers did not however amplify the expected
fragments in the vaccinal T1 strain of the organism. This suggested that there might be a
PI-like cytadherence gene in the virulent strains and that the gene may be missing in the
vaccine strain T1.
To eliminate the possibility that the two primer sets, MP-2 and MP-3 were unable to
amplify the expected fragments from the T1 strain because of inhibiting substances in the
DNA preparation and to ascertain its amplifiability, we designed a primer set, MP-V, from
the CAP-21 gene insert sequence described by Taylor et al, 1992. The primer set was
expected to amplify a 458 bp fragment in all members of the M. mycoides cluster. This
primer set amplified the expected 458 bp fragment in all the virulent strains as well as
several Tl vaccine strains. The primer set did not however amplify the fragment in the
closely-related M. pneumoniae and M. genitalium. Therefore this primer set provided
evidence that the Tl DNA was amplifiable and that the PI-like cytadherence gene may be
partially or totally missing from the Tl vaccine strain. To further investigate the latter
possibility, we compared the protein patterns of a virulent strain PG1 and that of the Tl
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vaccine strain. The two strains showed differences in several proteins including high,
medium and low molecular weight proteins one of which could be the PI-like gene
product.
A multiplex PCR assay was then developed using the MP-3 primer which amplifies
a 303 bp fragment only in the virulent strains and the MP-V primer which amplifies a 458
bp fragment in all strains both virulent and vaccine. The multiplex PCR assay amplified
two fragments (a 303 bp and 458 bp) in the virulent strains but only one fragment (the 458
bp) in the vaccine Tl strain. We used this multiplex PCR to test crudely prepared field
samples from herds suspected of CBPP infection. These herds were previously vaccinated
against CBPP with the Tl vaccine strain and later came down with what is thought to be
a CBPP-like syndrome. The assay did not amplify the 458 bp fragment in M. pneumoniae
and M. genitalium proving that both organisms do not belong to the M. mycoides cluster.
We are therefore reporting here the development and characterization of a multiplex PCR
assay that differentiates the virulent strains of M. mycoides subsp. mycoides “SC” Type
from the vaccine Tl strain, originally a virulent strain attenuated through passaging.
The multiplex PCR assay performed with a high degree of sensitivity and specificity.
The microbiological sensitivity was determined by establishing the least amount of DNA
that the assay can detect while the specificity was performed on human mycoplasmas
because we had no animal mycoplasmas to test the assay with. Both sensitivity and
specificity need to be further characterized.
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Conclusions:
(1). The multiplex PCR differentiated the virulent strains of M. mycoides subsp. mycoides
“SC” Type from the vaccine Tl strain with a high degree of sensitivity (up to 1:106
dilution) in relation to the organisms tested against it and specificity (Mp and Mg). The
ability of this assay to differentiate between these strains may have a profound impact on
the economy of Somalia by demonstrating that mycoplasma isolations from previously
vaccinated animals are in fact the Tl strain and not the virulent strains of the CBPP agent.
(2). The multiplex PCR assay can also be used to detect animals silently incubating the
disease and chronic carriers. This early detection will make it possible to take preventive
measures before large devastating outbreaks occur.
(3). The PCR technology is relatively easy to perform and most important is inexpensive.
Therefore, we can recommend it to the laboratories of the developing countries for
confirmatory diagnosis of diseases under control or eradicated when detected with other
means such as serology. Besides, this assay can settle disputes arising from the
interpretation of conventional methods of pathogen detection specially in Somali cattle
exports.
(4). Since we were forbidden by law to import live organisms into the United States of
mycoplasma strains, protein analysis was performed on ethanol-fixed cell lysates with
uninterpretable results. We recommend that the protein pattern comparison of the strains
be done in countries where the disease is endemic using freshly extracted proteins.
(5). Since we did not have the required samples to establish the epidemiological sensitivity
and specificity of the multiplex polymerase chain reaction (PCR) assay, it is necessary to
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test the sentivity with vaccinated animals when the application is the differentiation of
virulent strains from vaccine strains. If the application is detection o f the virulent strains,
then it is necessary to use animals that had been exposed to the disease.
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Appendix A. The sequence of the PI gene of M. pneumoniae
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C l u L y s L eu C l n C l y A le C lu A le

ACT CCT
T h r C ly

810
TCT TCA A(fc ACA TCT CCA TCT CCC CAA TCC
S e r S e r T h r T h r S eV C ly S e r C l y C l n S e r

140
ACC CAA CCT CCC CCT TCC TCA CCC
T h r C l n A rq C l y C l y S e r S e r C ly

CAC ACC
A sp T h r

870
AAA CTC AAC CCT TTA AAA ATA CAC CTC AAA
L ys V e l Lys A le L eu Lys l i e C lu V e l L y s

900
AAC AAA TCC CAC TCC CAC CAC AAT
L y e L y s S e r A sp S e r C lu A sp A sn

CCT CAC
C ly C ln

930
960
CTC CAC TTA CAA AAA AAT CAT CTC CCC AAC CCT CCC ATT AAC CCC ACC CAC CAC
L e u G in L eu C l u L y s A sn A sp L e u A l e A s n A l e P r o H e L y s A rq S e r C lu C l u

TCC CCT
S e r C ly

990
CAC TCC CTC CAA CTC AAC CCC CAC CAT T T T
C ln S e r V e l C l n L e u L y s A l e A sp A s p P h e

TCA CCC
S e r C ly

1050
1080
CCC AACTCC AAT CCC CCT TCC CCC ACC CCC TCA ACC CCC TCC CTT CCC ACT CAC
C ly A en S e r A s n P r o C ly S e r P r o T h r P r o T r p A r q P r o T r p L e u A le T h r C l u

CAA ATT
C ln Z le

1110
1140
CAC AACCAC CTC CCC AAA TCA TCC CCC TCC ATC CTC ATT CTC TAC CAT CCC CCT
K is L y s A sp L e u P r o L y s T r p S e r A l e S e r Z l e L e u H e L e u T y r A sp A le P r o

TAT CCC
T y r A le

1170
CCC AAC CCT ACC CCC ATT CAC CCC CTT CAT
A rq A sn A rq T h r A l e Z l e A sp A r q V e l A s p

1020
CCT ACT CCC CTT TCC ACT TCC CCA
C ly T h r A le L eu S e r S e r S e r C ly

1200
CAC TTC CAT CCC AAC CCC ATC ACC
H i s L e u A sp P r o L y s A le M et T h r

89
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CCS
A la

AACTAT CCC
A sn T y r P r o

1210
1263
CCC AST TCA ASA ACS CCC AAC TCA AAC CAC CAC CCT TTC TCC CAC TCA
P r o S « r T r p A r g T h r P r o L y s T r p A sn H i s H i s C l y L s u T r p A sp T r p

AAC
Lys

CCS CSC CAT
A l t A r c A sp

1293
1320
CTT TTC CTC CAA ACC ACC CCS TTC TTC AAC CCS CCC CSC CAC CCC CAC
V s l L s u L o u C l n T h r T h r C l y P h o P h s A sn P r o A r g A r g K is P r o C l u

T 5S TTT
T rp P hs

1350
1363
CATCCC CCS CAS ACC CTC CCS CAT AAC CAA AAC ACC CCC TTT CAT CTC CAT AAC
A sp C l y C l y s i n T h r V s l A l s A s p A s n C l u L y s T h r C l y P h s A sp V s l A sp A sn

T IT 3AA
l » r C lu

1*10
i««0
AACACC AAC CAC CCC TTT CAA AAC CAA CCT CAC TCC CAC AAC TCS CCC CCC ATC
A sn T h r l y s S i n C l y P n s C l n l y s C l u A ls A sp S s r A sp L y s S s r A l s P r o I l s

CCC
A ls

CTC CCC TTT
Lou P r o P h s

CAA, CCS TAC TTC
C lu A ls T y r , P hs

1*90
1500
CCC AAC ATT CCC AAC CTC ACC TCC TTC CCC CAA CCC
A l s A s n I l s C l y A sn L s u T h r T r p P h s C l y C ln A l s

CTT
ls u

TTC CTC TTT
L su V s l P h s

CCT CCC AAT CCC
C ly C ly A sn C ly

1530
1560
CAT C T T ACC AAC TCS CCC CAC ACC CCS CCT TTC ACT
K is V s l T h r L ys S s r A ls K is T h r A ls P ro L su S s r

ATA CCT
I l s C ly

1590
1620
CTC TTT ACC C TS CCC TAT AAT CCA ACT CCT ACC ACT CCT ACT CTA ACT CCT TCA
v s l P h s APT v s l A r g T y r A s n A l s T h r C l y T h r S s r A l s T n r V s l T h r C l y T r p

CCA TAT
P ro T y r

1650
16*0
CCCTTA CTC TTC TCA CCC ATC C T S AAC AAA CAA ACT CAC CCS TTA AAC CAT CTA
A l s L s u l s u P h s S s r C l y K s t V s l A s n L y s C l n T h r A sp C l y L s u L y s A sp L s u

CCC TTT
P ro Phs

1710
1740
AACAAT AAC CSC TCC TTT CAA TAT CTA CCA CCS ATC CCA CTT CCT CCC CCT AAC
A sn A sn A s n A r g T r p P n s C l u T y r V s l P r o A rg H sc A ls V s l A l s C ly A ls L y s

TTC CTT
P hs V sl

1770
H 00
CCTACS CAA CTC CTT TTA CCS CCT ACC ATT ACC ATC CCT CAT ACC CCT ACC CTA
c l y A rg C l u L s u V s l L s u A l s C l y T h r I l s T h r K s t c l y A sp T h r A ls T h r V s l

CCT CCC
P r o A rg

1*33
1660
TTA CTC TAC SAT CAA CTT CAA ACC AAC CTC AAC TTA CTA CCC CAA CCC CAA CCT
L s u L s u T y r A s p C l u l s u C l u S s r A s n L s u A sn L s u V s l A l s C l n C l y C l n C l y

CTT TTA
l s u L su

1*90
1920
CCCCAA CAC TTC CAA CTC TTC ACA CCC TAC CCA TCA CCC AAT CCT CCC CAT TTA
A rg C l u A s p l s u C l n L s u P h s T h r P r o T y r C ly T r p A l s A sn A rg P r o A sp L su

CCA
P ro

ATC CSC CCT
I l s C ly A ls

TCA ACT ACT AST
T rp S s r S s r S s r

1950
19*0
ACT A ST ACT ACT CAC AAC CCA CCC TAC TAC TTC CAC
S s r S s r S s r S s r H is A sn A l s P r o T y r T y r P h s K is
2010

2 0 *0

AAT AAC
A sn A sr.

CCCCAT TCA CAA CAC CCT CCA ATC CAA AAT CTC CTT CAT CCC TTT ATT AAC CCC
P r o A sp T r p C l n A sp A r g P r o I l s C l n A sn V s l V s l A sp A l s P h s I l s L y s P r o

TCA CAC
T r p C lu

2070
2100
CACAAC AAC CCT AAC CAT CAT CCC AAA TAC ATC TAC CCT TAC CCT TAC ACT CCC
A sp L y s A sn C l y L y s A sp A sp A l s L y s T y r I l s T y r P r o T y r A rg T y r S s r C ly

ATC TCA
K st T r?

2130
2160
CCTTCA CAC CTA TAC AAC TCC TC C AAT AAC CTC ACT CAC CAA CCA TTA ACT CCT
A ls T r p C l n V s l T y r A sn T r p S s r A s n L y s L su T h r A sp C l n P r o L s u S s r A l s

CAC TTT
A sp P h s

2190
2220
CTC AAT CAS AAT CCT TAC CAA CCA AAC TCC TTC TTT CCT CCT ATT CTC AAT CCC
V s l A sn C l u A s n A l s T y r S i n P r o A s n S s r L su P h s A l s A l s I l s L s u A sn P r o

CAA TTC
C l u L su

2250
22*0
TTACCA CCT CTT CCC CAC AAC C TT AAA TAC CCT AAC CAA AAC CAC TTT CCT CCT
L s u A l s A l s L s u P r o A s p L y s V s l L y s T y r C ly L y s C lu A sn C l u P h s A ls A l s

AAC CAC
A sn C lu

2310
23*0
TACCAC CCC T T T AAC CAS AAC TTA ACC CTA CCT CCT ACC CAA CCA ACA AAC TCA
T y r C l u A r g P n s A s n C l n L y s L s u T h r V s l A ls P r o T h r C l n C l y T h r A sn T r p

TCC CAC
S s r H i*

2370
2«oo
TTC TCC CCC ACC CTT TCC CCT TT C TCC ACC CCC TTC AAC CTT CTC CCC TCC CTC
P h s S s r P r o T h r L s u S s r A r g P h s S s r T h r C ly P h s A sn L s u v * l c l y S s r V s l

CTC CAC
L s u A sp

2*30
2460
CACCTC TTC CAT TAT CTC CCC TCC ATT CCC AAT CCC TAC ACC TAT CCC AAT AAC
C l n v s l L s u A s p T y r V s l P r o T r p I l s C l y A sn C l y T y r A rg T y r C l y A sn A sn

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

91

CAC CSC
K is A rq

24*0
2520
CCC CTC CAT CAT ATA ACC CCC CCT CAA ACC ACC CCC CCC TCC TCC ACC CCA ATT
C l y V s l A s p A sp I l s T h r A l s P r o C l n T h r S s r A l s C l y S s r S s r S s r C l y I l s

2550
2520
ACT ACC AAC ACA ACT CCT TCC CCT TCC T T T CTC CCC ACC T T T TCC AAC ATC CCC CTC CCC
S s r T h r A sn T h r S s r C l y S s r A rq S s r P h s L s u P r o T h r P h s S s r A s n I l s C ly V s l C l y
2S10
2*40
C CS CCC ACT CAC ACC ATC ATT ACA CSC CCT TCC
C l y C l y S s r C l n T h r H s t I l s T h r C ly C l y S s r

CTC AAA
L su L ys

CCCAAT CTC
A ls A sn V s l

CAA CCC ACC CTC
C ln A lt T h r L su

CCT CCA
P r o A rq

ACAACC CTC
A rq T h r L s u

2670
2700
CAC CAA CCC AAC CTC CAC CTC TCA ACC CCC CCC CCS TCA ACC AAT
A sp C ln A ls A sn L s u C l n L s u T r p T h r C l y A l s C l y T rp A rq A sn

CAT AAC
A sp L ys

CCT TCA ACT
A ls S s r S s r

2730
2760
CCA CAA ACT CAC CAA AAC CAC ACC AAC TTC ACC ACC CCT ACC CCC
C l y C ln S s r A sp c l u A s n M is T h r L y s P h s T h r S s r A ls T h r C ly

ATC CAC
H a t A sp

CACCAC CCA
C ln C ln C ly

2790
2*20
CAA TCA CCT ACC TCC CCC CCC AAT CCC CAC TCC TTA AAC CAC CAT
C l n S s r C l y T h r S s r A l s C l y A s n P r o A s p S s r L s u L y s C l n A sp

AAT ATT
A sn l i e

ACT AAC ACT
S s r Lys S e r

CCC CAT ACT TTA
C l y A sp S s r L s u

2*50
ACC ACC CAC CAC CCC AAT CCC
T h r T h r C ln A sp C ly A sn A ls

2**0
ATC CAT CAA CAA
I l s A sp C l n C ln

SAC CCC
C lu A ls

ACCAAC TAC
T h rA sn T y r

2910
ACC AAC CTC CCC CCC AAC CTC ACC CCC ACC CCT
T h r A sn L su P r o P r o A s n L s u T h r P r o T h r A l s

2940
CAT TCA CCC AAC
A sp T r p P r o A sn

CCS CTC
A la L su

TCA TTC ACC
S e r Phs T h r

2970
AAC AAC AAC AAC CCC CAC CCC CCC CAC CTC TT C
A sn L y s A sn A sn A l s C l n A r q A l a C l n L s u P n s

3000
CTC CSC CCC TTC
L s u A rq C ly L s u

TTC CCC
L su C ly

ACCATC CCC
S s r I l s P ro

3030
3 0 (0
CTC TTC CTC AAT CCA ACT CCC TCC CAT TCC AAC AAA TTC CAA CCC
V s l L su V s l A sn A r q S s r C l y S s r A a p S s r A s n L y s P h s C ln A ls

ACC CAC
T h r A sp

CAAAAA TCC
C ln L y s T r p

3090 ’
3120
TCC TAC ACC CAC TTA CAT TCC CAC CAA ACC AAA CTC AAC CTC CCC
S s r T y r T h r A sp L s u K i s S s r A s p C l n T h r L y s L s u Aqn L su P r o

3150
3 l« o
CCT TAC CCT CAC CTC AAT CCC TTC TTC AAT CCC CCC TTC CTC CAA ACC TAT TTT CCC AAC
A l a T y r C l y C l u V a l A sn c l y L su L s u A s n P r o A l a L s u V s l C l u T n r T y r P h s C ly A sh

ACC CCA
T h r A rq

CCS CCT CCT
A la C ly C ly

2 210
3240
TCC CCC TCC AAC ACC ACC ACT TCA CCC CCT ATC CCT TTT AAA ATT
S s r C ly S s r A sn T h r T h r S s r S s r P r o C l y I l s C l y P h s L y s I l s

3270
3300
CCC CAA CAA AAT AAT CAT TCC AAA CCC ACC CTC ATC ACC CCC CCC TTC CCT TCA ACC CCC
P r o C l u C l n A s n A s n A sp S s r L ys A ls T h r L s u I l s T h r P r o C l y L s u A l a T r p T h r P r o
3330
3360
CAC CAC CTC CCT AAC CTC CTT CTC ACT CCC ACC ACC CTC ACC TTC CAC CTC CCC CCC TCC
C l n A s p V a l C l y A s n ’ L e u V s l V s l S s r C l y T h r T h r V a l S s r P h s C l n L s u C ly C ly T r p
3390
3420
CTC CTC ACC TTC ACC CAC TTT CTC AAA CCC CCC CCC CCT TAC CTC CCT CTC CAC TTA ACC
L s u V a l T h r P h s T h r A sp P h s V s l L y s P r o A r q A l a C l y T y r L s u C l y L s u C ln L su T h r
3450
3 4 (0
CCC TTC CAT CCA ACT CAT CCS ACS CAC CCC CCC CTC ATT TCC CCC CCC CCC CCC TCA CCC
C l y L s u A sp A l a S s r A sp A la T h r C l n A r q A l a L s u I l s T r p A l a P r o A r q P r o T r p A la
3510
3540
CCC TTT CCT CCC ACT TCC CTC AAC CSC TTC CCC CCC CTC CAC ACT CTC TCC CAT TTC AAC
A l a P h s A rq C l y S s r T r p V a l A sn A rq L s u C l y A rq V a l C l u S s r V a l T r p A sp L su L y s
3570
3600
CCC CTC TCC CCC CAT CAA CCT CAC TCC CAC TCC CAA CCA TCT ACC ACC ACC CCA ACA ACC
C l y V a l T r p A l a A s p C l n A la C ln S s r A s p S s r C l n C l y S s r T h r T h r T h r A la T h r A rq
3630
3660
AAC CCC TTA CCC CAC CAC CCC AAT CCT TTC CCC TTT CAC CTC ACT CTC CTC CAA CCC ACT
A s n A l a L s u P r o C l u H i s P r o A sn A la L s u A la P h s C l n V a l S s r V a l V a l C lu A la S s r
3690
3720
CCT TAC AAC CCA AAC ACC ACC TCC CCC CAA ACC CAA TCC ACT AAC ACT TCC CCC TAC CTC
A l a T y r L y s P r o A s n T h r S s r S s r S l y C l n T h r C l n S s r T h r A sn S s r S s r P r o T y r L su
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CAC TTC
H is L eu

CTS AAC CCT
V al Lys P ro

J?SC
AAC AAA CTT ACC CAA TTC CAC
L y s L y s V a l T h r C l n S e r A sp

AACTTA CAC SAC SAT CTT AAA AAC
L y s L e u A sp A sp A sp Leu L y s A sn

CTC TTC
le u Leu

CAC CCC AAC
A sp P r o A s n

3H 0
CAC CTT CSC ACC AAC CTS CCC
C l n V a l A rg T h r L y s L e u A rg

CAAACC TTT CCT ACA CAC CAT TCC
C l n S e r P h e C l y T h r A sp K is S e r

ACC CAC
T h r C ln

CCC CAC CCC
P r o C ln P r o

3170
CAA TCC CTC AAA ACA ATC ACA CCC CTA TTT
C l n S a r L eu L y s T h r T h r T h r P r o V a l P h a

AAC CTC
A sn L e u

AST ACT CTC
S a r S a r V al

393C
CTT ACT CCT CSC CCT CCT CCA
L eu S e r C ly C ly C ly A la C ly

TCT CCC
S e r C ly

CTC CAT CTC
V a l A sp Leu*

3990
TCC CCC CTT CAA AAA CTC ACT CCC TCC CTT
S a r P r o V a > C l u L y s V a l S e r C l y T r p L au

CTC CCC CAC TTA CCA
V a l C l y C ln Leu P r o

ACC ACC
S a r T J ir

ACT CAC CCA
S a r A sp C l y

4053
AAC ACC TCC TCC ACC AAC AAC CTC CCS CCT
A sn T h r S e r S a r T h r A s n A sn L au A la P r o

AATACT AAT ACC CCC
A sn T h r A sn T h r C ly

4110
AAT CAT CTC CTC CCC CTT CCT CCA CTT TC T CAA ACC AAC CCC CCA
A sn A sp V a l V a l C l y V a l C l y A rq L e u S e r C l u S e r A sn A la A la

AACATS AAT SAC CAT
L ya K e c A en Aap A sp

4170
CTT CAT CCT ATT CTA CCC ACC CCA CTC CCT CAA CTC TTA CAT CCC
V a l A s p C ly H e V a l A rq T h r P r o L e u A l a C l u L e u L e u A sp C ly

CAACCA CAA ACA CCT
C lu c l y C ln T h r A la

4230
CAC ACT CCT CCA CAA ACC CTC AAC TTC AAC TCT CCT CAC CAA ATT
A sp T h r C l y P r o C l n S e r V a l L ya P h e L y s S e r P r o A sp C l n H e

CACTTC AAC CCC TTC
A sp P h a A sn A rg Leu

4290
TTT ACC CAC CCA CTC ACC CAT CTC TTT CAT CCS CTA ACT ATC TTC
P h e T h r K is P r o V a l T h r A sp L eu P h e A s p P r o V a i T h r K ec L eu

CTCTAT CAC CAC TAC
V a l T y r A sp C ln T y r

4350
ATA CCC CTC TTT ATT CAT ATC CCA CCA ACT CTC AAC CCT AAA ATC
H e P r o L eu P h e l i e A sp l i e P r o A la S e r V a l A s n P r o L y s H a t

CTT CCT TTA AAC CTC
V a l A rg Lau Lys V a l

4413
TTC ACC TTT CAC ACC AAC CAA CAC ACC TTA CCT CTC CCC TTA CAC
L eu S e r P h e A sp T h r A sn C l u C l n S e r L e u S l y L e u A r g Leu C lu

TTC TTT AAA CCT CAT
P h a P h e L y s Pr.o A sp

4470
CAA CAT ACC CAA CCA AAC AAC AAC CTT CAC CTC AAT CCC AAT AAC
S i n A sp T h r C l n P r o A sn A sh A sn V a l C l n V a l A s n P r o A sn A sn

CCT SAC TTC TTA CCA
C l y A sp P h e Leu P r o

4530
CTS TTA ACC CCC TCC ACT CAA CCT CCC CAA ACC TTC TTT ACT CCC
Leu L e u T h r A la S e r S e r C l n C l y P r o C l n T h r L e u P h e S e r P r o

TTT AAC CAC TCA CCT
p h e A sn C ln T r p P r o

3710

3140

3900

CCC ACC ACT ACT CCT
C l y T h r S a r S a r C ly

3960
CCCCCT TCT TCA CCC TCA CCT CJUl
C l y C l y S a r S a r C l y S a r C ly C ln
4020

4010

4140

4200

4260

4320

4310

4440

4500

4560

4590
CAT TAC CTC TTC CCC TTA CCC ATC ACT CTA CCT ATT
A sp T y r V a l L e u P r o L e u A l a Z l e T h r v a l P r o Z l e

CTT CTC ATT CTC CTC ACT CTT ACC
V s l V al H e V al Lau S a r V al T h r

4550
TTA CCA CTT CCC ATT CCA ATC CCA ATC CAC AAC AAC
L e u C l y L eu A la t i e C l y l i e P r o K e c K i s L y s A sn

AAA CAC CCC TTC AAC CCT CCC TTT
L y a c l n A la L e u L y s A la C ly P h e

4710
CCC CTA TCA AAC CAA AAC CTT CAT CTC TTC ACC AAA
A la L e u S e r A sn C l n L y s V a l A sp V a l L e u T h r L y s

CCCCTT CCT ACT CTC TTT AAC CAA
A l a V a l C ly S e r V a l P h e L y i C lu

4770
ATC ATT AAC CSC ACA CCT ATC ACT CAA CCS CCA AAA
Z l e l i e A sn A rg T h r C l y Z l e S e r C l n A l a P r o L y s

CCC TTC AAA CAA ACC ACT CCC CCT
A rg L eu L y s C l n T h r S e r A la A la

4130
AAA CCA CCA CCA CCC CCC CCA CCA CTA CCA CCA AAC
L y s P r o C l y A la P r o A rg P r o P r o V a l P r o P r o L y s

CCACCC CCT CCT AAC CCA CCA CTC
P r o C ly A la P r o L y s P r o P r o V a l

4610

4740

4100

4160

CAA CCA CCT AAA AAA CCC CCT TACTATTTATSAAATCCAACCTAAACTTAAAACCTTATTTACTCT 1 1 1 TAC
C l n P r o P r o L y e L y s P r o A la E n d
••
•• '
••
•
cacttttacccctag cacgttctca cta gccaa cacctacctcctccaaca ccacaa caccctcaccccctaca ogccc

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

K ID
F3 0

110
CAP
YGO
GLA

20

30

<10

50 ■

60

70

00

90

IOC

TTCrCAAGGACGVrCACTATATGCAGTAAA/\AOiAr;e - AAAACT 1‘AAAAAA TAATAAATCAAAT..............I'A •ATAAGTl IT - CTATATGAA - - -riV L V iA A l.
VrCTCAACGACGTl'CCCTATATCCACTAAAAACACCTAAAACTTAAAAAA TAATAAATCAAAT..............TAAATAAOTTT- GTATATGAA- - -TTAA3AAL
TTCTCAACGACCTTCACTATATCCAGTAAAAAGACC - AAAAGTTAAAAAA TAATAAA'l’C AAAT..............TA - ATAAGTGT - GT ATATGAA
1TAA0AAG
TTCACAACGACCTrCATTATATGGAGTAAAAAGACCT- AAAGTT AAAAAA T AAC AAAATAAATAGT AAT AAAT AAACCGTGTATATCAA - - A1TAAAAAC
TTCACAAGGACGTrCATTATATGGAGTAAAAACACCT-AAAGTl AAAAAA TAATAAAACAAA'VAA'VAAGTAAACCGT
GTATATCAA- -A1TAAAAAG
Tl'CACAAGGACGTTCATVATATGGAGTAAAAAAACCT- AAAGTTAAAAAA TAATAAAACAAATAATAATAAGTAAACCCTCTATATCTCAAATTAAA-LAG

120

130

140

150

160

170

100

190

200

F3 8

AACACATTAAAAGTAGCATATTTATATTAAAAAGAAAGGAGTTATrACCA
AACACATTAAAAGTACCATATTTATATTAAAAACAAAGCAGTTATTACCA
AACACATTAAAAGTAGCATATTTATATTAAAAACAAACGACTTArrACCA
AACACATTAAAAGTAGCATATrTATATTAAAAAGAAAGGAGTTATTACCA
AACACATTAA--GTACCATA'ITTATATT'AAAAACAAAGGAG'n'A'ITACCA
AACACATTAA--GTAGCATATTTATATTAAAAAGAAACGAG'lTATrACCA

TGCGTAAAAAT'AGAGCAGAAAAAAGAGATUTTTTACCACATCCAATT'TAT
TCCCTAAAAATACAGCACAAAAAAGACATCriTrACCACATCCAATTTAT
TGCCTAAAAATAGAGCACAAAAAACAGATGTnTAGCAGATCCAATTTAT
TGCGTAAAAATAAAGCAGAAAAAAOACATCTVTrACCAGATCCAATT7AT
'IGCGTAAGAATAGACCAGAAAAAAGACA'ICTnTAGCAGATCCAAnTAT
TGCGTAAGAATAGAGCAGAAAAAAGAGATGTm’AGCACATCCAATTTAT

CAP
YGO
GLA
BG7
KID
F3 8

210
220
230
210
250
AATTCTAAATTAGTTACTCGTCCAATTAATAAAATrATCTTAGATCGTAA
AATTCTAAA1TAGTTACTCGTGCAATTAATAAAATTATGTTAGATGGTAA
AATTCTAAATTAGTTACTCGTGCAATTAACAAAATT ATGTr AGATGGTAA
AATTCTAAATTAGTTACTCGTGCAATTAATAAAATTATGTTAGATGGTAA
AATTCTAAATTAGTTACTCGTGC AATTAATAAAATTATGTTAGATGGTAA
AATTCTAAATTAGTTACTCGTGC AATTAATAAAATTATGTTAGATGGTAA

260
270
200
290
230
AAGAGGAATTGCTCAGTCAVlTATTrATGA'I'GCATrTAATATAATTAAAC
AAGAGG AATl’GCTCAGTC AATTATTTATGA’l'CCATTT AATATAATTAAAG
AAGAGGAATT-C - - -GTCAATrATTTATCATCCATTTAATATAATTAAAG
AACAGGAATTCCTCAG7CAA1TATTTATGATCCATTTAATATAATTAAAC
AAGAGGAATTGCTCAGTC AATTATTTATGATCC ATTTAATATAATT AAAC
AACACGAATrGCTC ACTCAATrATTTATGATCCATTTAATATAATTAAAG

11G7
K ID
v£>

GJ

310

CAP
YCO
CLA

BG7
K ID
F3 8

320

330

340

350

360
370
300
390
CO
ATTAAACCTCACTTAGAATrAAAAGTTCGTCGTATTGGACGAGCTAAC7A
ATTAAACCTCACTTAGAATTAAAAGITCGTCGTATTCGACGAGCTAACTA
ATTAAACCTCACTTAGAATTAAAAGTTCGTCCTATTCGAGCACCTAAC7A
ATTAAACCICACITACAAVrAAAAGTTCGTCCTATTCGACGACCTAACTA
AAAAAACTAATAAAGAACCAATTGAAGTATTTAATAAAGCTATIGA'aAAT ATTAAACCTCATTTAGAA1TAAAAGT7CGTCGTATTGCAGGAGCTAAC7A
AAAAAACTAATAAAGAACCAATTCAACTATTTAATAAAGC7AT1CAAAAT ATTAAACC'ICATlTAGAA'ITAAAAG'rTCGTCCTAlTCGACGACCTAAC'TA

AAAAAACTAATAAAGAACCAATTGAACTATTTAATAAACCTATTCAAAAT
AAAAAACTAATAAACAACCAATTGAAGTATT7AATAAACCTA1TGAAAAT
AAAAAACTAATAAAGAACCAATTGAAGTATTTAATAAACCTA'ITi IAAAAT
AAAAAACTAATAAAGAACCAATTGAAGTA'nTAATAAAGCTATl’GAAAAT

Appendix B. The sequence of the CAP-21 gene insert.
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CAP
YGO
GLA
EG 7
K ID
F3 8

410
420
430
440
450
TCAAGTTCCrGTAGAAGTTTCAGCTGAAACACAAATCACTTTAGCTTTAC
TCAAC.TTCCTGTAGAAGTTrCAGCTGAAAGACAAATCACTTTAGCTTTAC
TCAACTTCCTATAGAAGnTAACCTGAAAGACAAATCACTTrAGCn^rAC
TCAAGTTCCTCTAGAAGTTTCACCTGAAAGACAAATCACTTTAGCTITAC
TCAAGTTCCTGTAGAAGTTTCAGCTGAAAGACAAATCACTTTAGCTTTAC
TCAAGTTCCTGTAGAAGTTTCAGCTGAAAGACAAATCACTTTAGCTTTAC

460
470
480
490
SOI
GTTGATTAATTAATTATCCAAGATTAAGAAACCAAAAAGTTA7CACAAT:
GTTGATTAATTAATTATGCAAGATTAAGAAACCAAAAAGTTATGACAATC
GT'l’GATTAA'IT’AATTA'l'GCAAGATTAAGAAACGAAAAACTTATGACAATT
GTTGATT AATT AATTA’IGCAAGATTAAGAAACGAAAAAGTTATGAC AATT
CTTGATTAATTAATTATCGAAGATTAAGAAACGAAAAAGTTATGACAATT
GTTGATTAATTAATTATGCAAGATTAAGAAACGAAAAAGTTATGACAATT

CAP
YGO
GLA
BG7
KID
F38

510
520
530
540
550
AAATTAGCTAATGAAATTATTGATCGATCAAATAATATTGGTGGATCAGT
AAATTAGCTAATGAAATTATTGATGC ATC AAATAATATTGGTGGATCAGT
AAATGAGCTAATGAAATTATTGATGCATCAAATAATATTGGTGGATCAGT
AAATTAGCTAATGAAATTATTGATGCATCAAATAATATTGGTGGATCAGT
AAATTAGCTAATGAAATTATTGATGCATCAAATAATTTTGGTGGATCAGT
AAATTAGCTAATGAAATTATTGATCGATCAAATAATATTGGTGGATCAGT

560
570
580
590
600
TAAAAAACGTGAAGATACTCATAAAATGGCAGAACGAAATAAAGCGTTTG
TAAAAAACGTGAACATACTCATAAAATGGCACAAGCAAATAAAGCGTTTG
TAAAAAACGTGAAGATACTCATAAAATGGCACAACCAAATAAAGCGTTTG
TAAAAAACCTGAAGATACTCATAAAATGGCACAAGCAAATAAAGCATTTG
TAAAAAACGTGAAGATACTCATAAAATGGCAGAAGCAAACAAAGCATTTG
TAAAAAACGTGAAGATACTCATAAAATGGCAGAAGCAAACAAAGCATTTG

___ •

_

M

610
CAP
YGO
GLA
BG7

KID
F38

•

GLA

BG7
K ID

F38

640

•

710
YGO

630

650

CTCATTATCGTTGATAATCAAA
TTAGAAAGGAAAATAC-GAAA
CTCATTATCGTTGATAATCAAA
TTAGAAAGGAAAATAC-GAAA
CACACTATCGTTGATAATCAAA
TTAGAAAGGAAAATAG-CAAA
CACACTATCGTTGATA.......................... ........... TTAGAAAGGAAAATTAATAAA
CACACTATCGTTGAT
C - - ATT - AGAATTAGAAAGG AAAATTAATAAA
CACACTATCGTTG- -A A T - -A A TT AAGAATTAGAAAGG AAAATTAATAAA
•

CA P

620

•

660

670

720

730

740

680

m

750

•

*

690

700

TGGCTAGAGAATACAGTTTATTAAATACTCGTAATATTGGTATTATGGCT
TGGCTAGAGAATACAGTTTATTAAATACTCGTAATATTGGTATVATGGCT
TGGCTAGAGAATACAGTTTATTAAATACTCCTAATATTGGTATTATGGCT
TGGCTAGAGAATACAGTTTATTAAATACTCGTAATATTGGTATTATGGCT
TGGCTAGAGAATACAGTTTATTAAATACTCGTAATATTGGTATTATGGCT
TGGCTAG AGAATAC AGTTTATTAAATAATCG AAATATT - CAATTATGGCT

• • • •

CATATTGATGCTGGTAAGACTACTACTACTGAACGTATTTTATTTCATAC
CATATTGATGCTGGTAAGACTACTACTACTGAACGTATTTTATTTCATAC
CATATTGATGCTCGTAAGACTACTACTACTCAACGTATTTTATTTCACAC
AATATTGATGCTGGTAAGACTACTACTACTGAACGTATTrTATTTCACAC
AATATTGATCCTGGTAAGACTACTACTACTGAACGTAT7T TATTTCACAC
CATATTGATGCTGGTAAGACTACTACTACTGAACGTATTTTATTTCACAC
•

*•

760

770

780

m

ft

790

*

800

TGGAAAAATTCACAAAATACGTGAAACACATGAAGGTCCTTCACAAATCG
TGCAAAAATTCACAAAATAGGTGAAACACATGAGGGTGCTTCACAAATGG
TGCAAAAATTCACAAAATAGGTGAAACACATGAAGGTGCTTCACAAATGG
TGGAAAAATTCATAAAATAGGTGAAACACATGAACGTGCTTCACAAATGG
TGGAAAAA TTC ACA AAAT AGGTG AAAC ACATGAAGGTGCTTCACAAATGG
TGGAAAAATTCACAAAATACGTGAAACACATGAAGGTCCTTCACAAATCG
•

sO

Appendix C:
Gel and buffers for the SDS-PAGE:

12% Seperating Gel:
Acrylamide (30%)
dH20

20 ml
16.75 ml

1.5M TRIS-HC1 pH 8.8

12.5 ml

10% SDS

500 fA

10% Ammonium persulfate

250 tA

Temed

25 (A

Total

50 ml

4% Stacking Gel:
Acrylamide (30%)

1.3 ml

dH20

6.1 ml

0.5M TRIS-HCI pH 6.8

2.5 ml

10% SDS

100//I

10% Ammonium persulfate

50 a^I

Temed

10 a*1

Total

10 ml
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SDS-PAGE Buffers:
a. Sample Buffer
dH20

3 ml

0.5M TRIS-HC1 pH 6.8

1 ml

Glycerol

1.6 ml

10% SDS

1.6 ml

B-mercaptoethanol

0.4 ml

0.5% bromophenol blue

0.4 ml

Total

8 ml

b. Running Buffer
lOx SDS-TRIS-GIycine buffer (Bio-Rad) diluted to lx.
This was used both electrode buffer and running buffer.

C. Staining Solution:
40% Methyl alcohol
10% Acetic acid
0.1% Comassie blue

d. Destaining Solution:
40% Methyl alcohol
10% Acetic acid
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